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  Abstract 
 
Recent research on adult onset Attention Deficit/Hyperactivity Disorder (ADHD) has led to an 
increase in evaluations of college students and adults suspected of the disorder, as well as 
increased concern that some may feign or malinger ADHD characteristics in order to obtain a 
diagnosis and associated incentives (e.g., stimulant medications and academic accommodations).  
Faking ADHD is especially easy when the diagnosis is based on self-report, symptoms-only 
rating scales.  Diagnostic accuracy improves with the assessment of symptoms, impairment, and 
symptom validity, but this type of comprehensive self-report measure is currently not available.  
The aim of this study was to examine the effectiveness of a newly constructed Multidimensional 
ADHD Rating Scale (MARS) comprised of ADHD symptom, functional impairment, and 
symptom validity indexes.  The MARS self-report items were completed by three groups of 
college-aged students.  Participants with ADHD (n=39) and non-ADHD controls (n=62) 
completed the MARS honestly.  A group of non-ADHD participants (n=56) were instructed to 
malinger ADHD.  Results indicated that malingerers reported more symptoms and impairment 
than ADHD participants, and both groups reported more symptoms and impairment than 
controls.  The symptom validity index was able to differentiate malingerers from ADHD 
participants with high sensitivity and specificity. These preliminary results suggest that measures 
that combine symptoms, impairment, and symptom validity could be useful additions to ADHD 
rating scales. 
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The Construction of a Multidimensional ADHD Self-Report Measure: A Pilot Study 
 
ADHD (Attention Deficit/Hyperactivity Disorder) is a neurodevelopmental disorder 
commonly referred to mental health professionals for both diagnosis and treatment.  ADHD is 
currently diagnosed in 11% of children (CDC, 2014).  Although exact prevalence rates are 
unknown, ADHD is estimated to occur in 5% of the college-aged population (DuPaul, Weyandt, 
O’Dell, & Varejao, 2009; Harrison, 2004).  Due to the high prevalence rate, it is not surprising 
that ADHD accounts for one of the largest disability groups on college campuses (Weyandt & 
DuPaul, 2006).  In addition, college-aged self-referrals for evaluations have risen, related in part 
to an increase in public awareness about adult ADHD (Barkley, Murphy, Fischer, 2008).  
University health clinics as well as community mental health practitioners are often the 
gatekeepers to an adult ADHD diagnosis and access to treatment (Barkley, Murphy, Fischer, 
2008).  Treatments such as stimulant medication (e.g., Ritalin, Adderall) and access to academic 
accommodations (e.g., extended time on tests) potentially incentivize students to seek an ADHD 
diagnosis.   
Clinicians report using rating scales and clinical interviews to make a diagnosis of 
ADHD in adults (Musso & Gouvier, 2014; Nelson, Whipple, Lindstrom & Foels, 2014).  These 
methods have been shown to be highly subjective and susceptible to diagnostic errors (e.g., 
Musso & Gouvier, 2014; Marshall et al., 2016).  To begin, ADHD symptoms are non-specific, as 
they are frequently reported within the general population (Murphy & Barkley, 1996) and with 
other disorders (e.g., learning disabilities, anxiety disorder, conduct disorder, autism spectrum 
disorder; Barkley, 2014).  Second, some individuals may perceive themselves as having relative 
weaknesses compared to their peer group and unintentionally over-report symptoms (Barkley, 
2014).  Finally, ADHD is susceptible to malingering, or conscious over-reporting or feigning 
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performance to obtain external incentives (e.g., Quinn, 2003).  The incentives to an ADHD 
diagnosis (e.g., medications, academic accommodations) increase the chances of malingering 
among college-aged self-referrals for ADHD (Musso & Gouvier, 2014).  Although exact rates of 
malingering are unknown, noncredible psychological test performance has been reported to be as 
high as 30% (Suhr, Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008) to 47% (Sullivan, 
May, & Galbally, 2007) of college self-referrals for ADHD.  Lastly, college students without 
ADHD have demonstrated that they can report ADHD symptoms on rating scales to obtain the 
diagnosis (e.g., Jachimowicz & Geiselman, 2004; Quinn, 2003).  In contrast, some individuals 
with ADHD have been known to under-report symptoms and impairment (e.g., Prevatt et al., 
2012; Sibley et al., 2012).  Because many evaluations focus on elevated symptom presentation to 
diagnose ADHD, both under and over-reporting of symptoms could lead to inaccurate diagnostic 
decisions, which results in increased public and private costs (Aldridge, Kroutil, Cowell, Reeves, 
& Van Brunt, 2011; Chafetz & Underhill, 2013). 
One method to improve detection of malingering is the use of a symptom validity test as 
part of an assessment.  In self-report measures, these validity scales are designed to measure 
respondent honesty, consistency, minimization of impairment (i.e., fake good), and maximization 
of impairment (i.e., fake bad).  Valid responding on these scales increases confidence in making 
accurate diagnostic decisions.  Test developers have incorporated validity scales into various 
personality (e.g., Personality Assessment Inventory; Morey, 1991) and behavioral rating 
measures (e.g., Behavior Assessment System for Children-2nd edition; Reynolds & Kamphaus, 
2004).  However, despite the recognized need for validity tests, few ADHD rating measures 
contain a validity scale.   
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One ADHD self-report measure with a validity test is The Clinical Assessment of 
Attention Deficit-Adult (CAT-A; Bracken & Boatwright, 2005).  The CAT-A utilizes an 
infrequency validity scale, which contains items that are not highly endorsed within the ADHD 
population.  High endorsement on these infrequency items indicates possible over-reporting of 
symptoms and probable malingering.  The CAT-A validity scale has better psychometric abilities 
to detect malingering than any other existing ADHD rating scale, although the sensitivity (58%) 
rate falls short of what is recommended to make confident diagnostic decisions (Marshall et al., 
2010).   
The Conners’ Adult ADHD Rating Scale (CAARS; Conners, Erhardt, & Sparrow, 1998) 
is a commonly used adult ADHD rating measure that has validity scales that are unreliable 
measures of malingered ADHD (e.g., Suhr et al., 2008).  To improve malingering detection on 
the CAARS, Suhr, Buelow, and Riddle (2011) created a 12-item Infrequency scale using the 
scale’s current ADHD symptom items.  Although initial results for this scale were promising, 
subsequent research found low sensitivity (32%) and specificity (65%) rates (Fuermaier et al., 
2016).  The infrequency scale drew items directly from the ADHD symptom items, and these 
items would presumably be endorsed by both individuals with ADHD and those malingering 
ADHD.  In order to increase discriminative abilities of a scale to detect malingering, items need 
to be specifically designed to be infrequently endorsed by those with ADHD yet endorsed 
frequently by malingerers.  The CAARS Infrequency scale did not accomplish this. 
As Wakefield (2010) and others have noted, clinicians are at-risk for false positive 
ADHD diagnoses when their assessment focuses on symptoms-only, and does not account for 
current or past functional impairment (e.g., Bird et al., 1988; DuPaul, Reid, Anastopoulos, & 
Power, 2014).  If clinicians rely heavily on self-reported rating scales to make ADHD diagnoses, 
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then they need rating scales with sound psychometric properties that include a validity 
component, as well as a method of jointly assessing both symptoms and functional impairment.  
This type of multidimensional ADHD measure is not available, yet could be a valuable tool for 
making more accurate diagnostic decisions..   
The purpose of this study was to construct and pilot test a multidimensional rating scale 
to assess ADHD and detect malingering in the college age population.  This multidimensional 
rating scale included three components that should be considered collectively when making a 
diagnosis of ADHD.  Two of these components—ADHD symptoms and functional 
impairment—are needed to identify cases of ADHD.  The third component involves an 
exploratory symptom validity index intended to validate self-report and to detect malingered 
ADHD.   
This preliminary study included three aims.  First, this study created a symptom validity 
index comprised of items that individuals with ADHD infrequently endorsed (i.e., exaggerated 
symptoms that do not reflect known ADHD symptoms), but were endorsed by college students 
coached to malinger ADHD.  Second, this study analyzed whether there would be response 
differences between ADHD, malingered ADHD, and controls on the ADHD symptom, 
functional impairment, and symptom validity indexes.  Lastly, this study conducted preliminary 
analyses of the classification accuracy of each index to identify true cases of ADHD from those 
that are malingering ADHD.  
Attention Deficit / Hyperactivity Disorder 
 DSM-5 Diagnostic Criteria.  Attention Deficit / Hyperactivity Disorder (ADHD) is 
defined in the Diagnostic and Statistical Manual for Mental Disorders-Fifth Edition (DSM-5; 
American Psychiatric Association, 2013b) as a neurodevelopmental disorder characterized by 
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symptoms of inattention and hyperactivity that begins prior to the age of 12.  The DSM-5 
diagnostic criteria are as follows: 
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development, as characterized by symptoms within (1) and/or (2): 
1. Inattention: Six (or more) of the following symptoms have persisted for at least 6 
months to a degree that is inconsistent with developmental level and that 
negatively impacts directly on social and academic/occupation activities.  Note: 
For older adolescents and adults (age 17 and older), at least five symptoms are 
required: 
• Often fails to give close attention to details or makes careless mistakes 
in schoolwork, at work, or with other activities. 
• Often has difficulty sustaining attention in tasks or play activities. 
• Often does not seem to listen when spoken to directly. 
• Often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace. 
• Often has trouble organizing tasks and activities. 
• Often avoids, dislikes, or is reluctant to do tasks that require mental 
effort over a long period of time. 
• Often loses things necessary for tasks and activities. 
• Is often easily distracted by extraneous stimuli. 
• Is often forgetful in daily activities. 
2. Hyperactivity and Impulsivity: Six or more symptoms of the following symptoms 
that have persisted for at least 6 months to a degree that is inconsistent with 
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developmental level and that negatively impacts directly on social and 
academic/occupational activities.  Note: For older adolescents and adults (age 17 
and older), at least five symptoms are required: 
• Often fidgets with or taps hands or feet, or squirms in seat. 
• Often leaves seat in situations when remaining seated is expected. 
• Often runs about or climbs in situations where it is not appropriate 
(adolescents or adults may be limited to feeling restless). 
• Often unable to play or take part in leisure activities quietly. 
• Is often "on the go" acting as if "driven by a motor.” 
• Often talks excessively. 
• Often blurts out an answer before a question has been completed. 
• Often has trouble waiting his/her turn. 
• Often interrupts or intrudes on others. 
B. Several inattentive or hyperactive-impulsive symptoms were present prior to the age 12 
years. 
C. Several inattentive or hyperactive-impulsive symptoms are present in two or more 
settings (e.g., home, school or work, with friends or relatives). 
D. There is clear evidence that symptoms interfere with, or reduces quality of life of social, 
academic, or occupational functioning. 
E. The symptoms do not occur exclusively during the course of schizophrenia or another 
psychotic disorder and are not better explained by another mental disorder (e.g., mood 
disorder, anxiety disorder, dissociative disorder, personality disorder, substance 
intoxication or withdrawal) (American Psychiatric Association, 2013, pg. 59-65). 
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Based on the 18 symptoms listed above, three types (presentations) of ADHD can occur.  
The Combined Presentation requires that symptoms of both inattention (A1) and hyperactivity-
impulsivity (A2) criteria are met for the past 6 months.  The Predominantly Inattentive 
Presentation is if Criterion A1 (inattention) is met, but not Criterion A2 (hyperactivity-
impulsivity), for the past six months.  The last specifier is the Predominantly Hyperactive-
Impulsive Presentation, which occurs if Criterion A2 (hyperactivity-impulsivity) is met, but 
symptoms do not meet Criterion A1 (inattention), for the past six months (American Psychiatric 
Association, 2013).         
 In addition to the denoted DSM-5 symptoms of inattention and hyperactivity-impulsivity, 
ADHD is often associated with global deficits in executive functioning skills.  These can include 
difficulties with planning, organizing, working memory, cognitive flexibility, set shifting, and 
inhibitory control (Barkley, Murphy, Fischer, 2008).  The DSM 5 symptoms and associated 
executive function deficits should be manifested across time (including childhood) and settings 
(Criteria B and C respectively).  Most importantly, the symptoms and other associated deficits 
must interfere with or reduce one’s quality of functioning (Criterion D).  
 The Legal Definition of Disability.  The assessment of impairment is a significant 
eligibility criterion for any disability as defined under The Americans with Disabilities Act 
Amendments Act (ADAAA, 2008).  The ADAAA is federal legislation that provides individuals 
with disabilities reasonable accommodations and/or modifications designed to equalize access to 
employment, education, and other public services.  To qualify as an individual with a disability 
under the ADAAA, there must be evidence of a disability (i.e., physical or mental impairment) 
that substantially limits an individual in at least one major life activity (e.g., bathing, reading, 
thinking, concentrating).  In other words, a diagnosis may not be sufficient to warrant a legal 
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definition of disability.  To qualify for academic accommodations, for example, individuals must 
provide adequate documentation, proving his/her impairments limit a major life activity and 
restrict access to educational and/or occupational opportunities (ADAAA, 2008).  It is therefore 
possible that a person could receive a diagnosis of ADHD yet not meet the ADAAA definition of 
disability.  For example, without a substantial limitation in reading, writing, or concentrating, a 
person with an ADHD diagnosis might be considered not qualified or eligible for 
accommodations.  In summary, the DSM 5 requires that symptoms interfere with functioning, 
and the ADAAA requires documentation of impairment to establish eligibility.  Therefore, it is 
important that a comprehensive evaluation include the assessment of both symptoms and 
associated impairment. 
The Importance of Assessing Symptoms and Functional Impairment 
The joint assessment of symptoms and impairment satisfies the DSM-5 criteria for a 
diagnosis, as well as helps to provide documentation towards establishing a substantial limitation 
for the ADAAA requirement.  Symptoms and impairment are two important, but different 
constructs.  Barkley and colleagues (2006) distinguish between symptoms and impairment by 
defining the former as “the behavioral expressions associated with the disorder” and the latter as 
“the consequences that ensue for the individual as a result of these behaviors” (Barkley et al., 
2006, p. 2).  Despite this distinction, it seems that many clinicians treat these two factors as one, 
and prefer to rely on symptom rating scales in an assessment (Musso & Gouvier, 2014; Nelson et 
al., 2014).  However, the practice of a symptoms-only assessment and presumption of 
impairment can be problematic and may increase the chance of making a false positive diagnosis 
(Wakefield, 2010).  
It is accurate to say that there is a positive linear relationship between ADHD symptoms 
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and impairment (e.g., Gathje, Lewandowski, & Gordon, 2008).  However, the strength of this 
association is dependent upon the measures and the population being studied.  For example, 
Fabiano and colleagues (2006) found higher correlations (r = .58 - .93) in a child clinical 
population in comparison to a general elementary school sample (r = .17 - .53).  Gordon and 
colleagues (2006) examined several datasets involving children referred for ADHD assessments 
and found moderate correlations (r = ~.30) between symptoms and various measures of 
impairment.  Barkley (2006) on the other hand, found higher correlations (r = .43 - .88) when 
impairment was assessed across multiple domains of functioning.  It appears that the relationship 
between symptoms and impairment is stronger when impairment is measured across multiple 
domains, as opposed to one or two specific domain areas.  Additionally within the adult 
population, correlations between symptoms and impairment were higher for same source ratings 
(e.g., self-report) as opposed to two different sources (e.g., self-report and parent report) 
(Barkley, Murphy, Fischer, 2007).  Overall, the research indicates that there is a relationship 
between symptoms and impairment; however, the degree of the relationship is dependent upon 
various factors.  ADHD symptoms alone do not completely account for impairment levels, thus 
both warrant independent measurement and consideration in the diagnosis of ADHD.  
With the knowledge that symptoms and impairment are two distinct yet related factors, it 
is not surprising that joint assessment can reduce false positive rates.  For example, one study 
(Bird et al., 1988) found that 49.5% of children in the general population met the symptom 
criteria for ADHD.  However, only 17% also met the functional impairment criterion needed for 
a true diagnosis of ADHD.  Shaffer and colleagues (1996) found that 4.5% of the study’s sample 
met ADHD symptoms criterion, yet only 2.8% met both the symptoms and functional 
impairment criteria (Shaffer et al, 1996).  In a recent national study, DuPaul and colleagues 
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(2014) asked 1,070 teachers to rate symptoms and functional impairments for two randomly 
selected students in his/her 6th-12th-grade classroom.  From the total sample, 18.9% of students 
met the symptom count and 31.4% met the functional impairment count.  However, the sample 
rate reduced to 7.3% when both symptoms and functional impairment count were considered 
jointly, which is closer to accepted epidemiological base rates (DuPaul, Reid, Anastopoulos, & 
Power, 2014). 
The above research, coupled with the DSM-5 and ADAAA guidance for disability 
diagnosis, strongly suggest that clinicians should consider both symptoms and impairment in 
their diagnostic determinations.  Not only does this practice improve diagnostic accuracy 
(Barkley et al., 2006; Gordon et al., 2006), but it is impairment in daily life activities that leads 
individuals to seek treatment (Barkley, Murphy, & Fischer, 2007).  Additionally, although 
medications can be helpful, not everyone with ADHD will respond to stimulants, and some 
individuals will continue to report persistent and significant difficulties in impairment in daily 
activities after stimulant treatment (Lerner, 2010). Although medication can help to reduce 
symptom severity (e.g., excessive movement), it is not always the solution to difficulties in daily 
life functioning (Lewandowski, Lovett, & Gordon, 2009).  For example, one study found that 
over 50% of adults with ADHD still experienced difficulties in major life activities, despite 
having a reduction in symptom severity with medication (Safren, Sprich, Cooper-Vince, Knouse, 
& Lerner, 2010).  This suggests that intervention programs should target both symptom and 
impairment levels.  This also indicates that both symptoms and impairment are needed to truly 
monitor treatment efficacy and effectiveness over time (Gordon et al., 2006).  Overall, the 
assessment of both symptoms and impairment, as recommended by DSM and ADAAA, should 
lead to more accurate diagnoses and more effective treatment plans. 
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Weaknesses of Current ADHD Rating Scales 
Although diagnostic criteria and legislation recommend the joint assessment of symptoms 
and impairment, it appears as if impairment is not being assessed routinely in clinical practice.  
Recently, Nelson and colleagues (2014) examined psychological reports submitted as 
documentation from college students claiming to have ADHD and seeking test accommodations.  
This study found that all cases relied upon rating scales, with 84% documenting current 
symptom severity.  Some form of current impairment was documented in 59% of the reports, but 
this was based primarily on the results of academic achievement tests, as opposed to any specific 
impairment rating measure. Yet, only 28% of cases reported both symptoms and impairment.  
The authors noted that only 1% of the psychological reports documented that students met all 
DSM-5 criteria for ADHD (i.e., current and childhood symptoms and impairment), yet 87% of 
the reports recommended at least one test accommodation.  These findings indicate that the 
documentation to support the ADHD diagnosis may be largely inadequate.  Documentation of 
ADHD should involve objective data from records and testing, measures of symptoms and 
impairment, as well as the assessment of symptom validity (e.g., American Academy of 
Pediatrics, 2011).  Currently there is no multidimensional assessment tool that assesses ADHD 
symptom presentation, symptom validity, and functional impairment. 
Unfortunately, the diagnostic reliance on symptoms-only rating scales is prone to error 
that can threaten the validity of diagnosis.  As alluded to in the aforementioned studies (Bird et 
al., 1988; DuPaul et al., 2014; Shaffer et al., 1996), ADHD symptoms are common in the general 
population of children and adults.  For example, Murphy and Barkley (1996a) surveyed 720 
adults from the general population who were renewing driver’s licenses.  Consistent with 
prevalence estimates, 4.6% of these individuals within the general population met the DSM-IV 
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symptom criterion of six or more symptoms.  However, subthreshold ADHD symptoms were 
reported in 22% of the symptom reports and in 56% of childhood retrospective symptom reports.  
Similarly, Lewandowski and colleagues (2008) found subthreshold ADHD symptoms within the 
general college population.  On average, the non-ADHD group endorsed “often/always” for 4.5 
out of the 18 ADHD symptoms (Lewandowski, Lovett, Codding, & Gordon, 2008).  Overall, 
these studies suggest that a sizeable minority of the non-ADHD adult population report 
subthreshold ADHD symptoms on ADHD rating scales.  
Given the frequency of subthreshold ADHD symptoms in the general population, it is 
important that rating scales utilize an adequate response scale cutpoint to minimize the chance of 
identifying these subthreshold levels.  In a study of 314 children referred to an outpatient 
psychiatry clinic in central New York, 81% met a liberal threshold (one standard deviation above 
the mean) for diagnosis based on maternal report of ADHD symptoms alone.  At a threshold of 
1.5 standard deviations, diagnostic rates reduced to 60% using a symptoms-only approach.  The 
rates declined further (19%) when both symptoms and impairment were jointly assessed.  When 
an even more stringent criterion on the impairment measure (two standard deviations) was 
required, the classification rate dropped to less than 1% (Gathje, Lewandowski, & Gordon, 
2008).  This study demonstrates that one should not only jointly assess symptoms and 
impairment, but a well-validated response scale cutpoint is needed to prevent over- or under-
diagnosis. 
Across all types of rating scales, there are concerns that items are subjective and 
respondents may misinterpret or erroneously report symptom severity.  Rating scales responses 
are impacted more by one’s current emotional state rather than an objective viewpoint (Miller et 
al., 2013).  Additionally, to meet the DSM-5 criteria, ADHD symptoms should be present before 
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the age of 12 (American Psychiatric Association, 2013).  This information is frequently obtained 
in a clinical interview with the adult recounting childhood ADHD symptoms.  However, research 
has demonstrated that adults are not reliable in reporting retrospective memories of childhood 
symptoms (Barkley, Fischer, Smallish, & Fletcher, 2002; Barkley, Knouse, & Murphy, 2011).  
Therefore, both current and retrospective reports of symptoms may be prone to the same 
subjectivity and bias, and therefore, could easily lead to false positive ADHD diagnoses.    
There are also concerns that some individuals with ADHD may under-report symptoms 
and impairment compared to parent and other collateral reports (e.g., Dvorsky, Langberg, 
Molitor, & Bourchtein, 2016; Sibley et al., 2012).  In other words, true positives could be missed 
in an assessment based only on symptom report.  This has been ascribed to the positive illusory 
bias, or cases in which individuals self-report higher levels of competence compared to his/her 
actual performance.  The positive illusory bias is considered a strategy that frequently occurs in 
both disability and non-disability populations (Owens et al., 2007).  However, the positive 
illusory bias can become maladaptive when an individual is unaware of his/her failures and thus 
unable to correct them.  This positive bias occurs frequently in children with ADHD (Owens et 
al., 2007).  Prevatt and colleagues (2012) found that these overly positive self-views may extend 
into the college years.  Although college students with ADHD reported higher impairment levels 
compared to college students without ADHD, there was evidence of the positive illusory bias on 
an individual level.  On the individual self-reports, those with ADHD reported overly positive 
global domains of functioning (e.g., driving) in comparison to self-reported impairment on the 
specific behaviors within those domains (Prevatt et al., 2012).  This suggests that the positive 
illusory bias is present in college students.  In fact, due to biased responding found among 
college students with ADHD, some have recently argued for the need to collect collateral reports 
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(e.g., parents) to validate self-reported symptom and impairment (Dvorsky et al., 2016; Sibley et 
al., 2012).   In general, clinicians should be aware that individuals with ADHD may under-report 
both symptoms and impairment compared to their actual performances, especially if they are 
only asked about global domains of functioning.   
In summary, although rating scales are important in the diagnostic process, they are 
fallible.  Clinicians are susceptible to false positive and negative diagnoses when relying upon 
these measures exclusively, especially when impairment is overlooked in the assessment 
(DuPaul et al., 2014).  Not only are rating scales generally susceptible to error when an 
individual is honestly responding, they also are easy to fake or exaggerate to obtain a diagnosis.  
Unfortunately, as will be discussed, ADHD scales are no different and are easily deceived by 
those consciously faking ADHD (e.g., Quinn 2003).  There are potential incentives conferred by 
an ADHD diagnosis, including stimulant medication, academic resources, test accommodations, 
as well as ADAAA rights and protections (Musso & Gouvier, 2014).  These incentives may 
increase the risk of biased responding, and further support the need for clinicians to validate 
responding and assess for malingering in ADHD evaluations.  
Malingered ADHD 
 Definitions of Malingering.  As discussed, subjective ratings of one’s own symptoms 
can be easily biased.  In some cases, they are exaggerated due to the presence of internal and 
external incentives.  An individual may be internally motivated to obtain a diagnosis in order to 
help explain his/her difficulties or to confirm a pre-determined self-diagnosis of ADHD 
(Barkley, Murphy, Fischer, 2008; Barkley, 2014).  In addition, individuals can be motivated by 
external incentives (e.g., medication, academic accommodations) to consciously exaggerate 
symptoms.  In the DSM 5, malingering is used as a differential diagnosis or V-code in the DSM 
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for other disorders.  It is defined as the intentional and conscious choice by an individual to 
erroneously provide false information in order to obtain external incentives (American 
Psychiatric Association, 2013).  Although unconscious and conscious attempts to falsify 
information can impact the diagnostic process in any setting, malingered ADHD on college 
campuses has been the focus of recent research.   
To further operationalize the DSM-5 definition, Iverson (2006) defines malingering as the 
conscious use of poor effort and/or exaggeration during the assessment.  Poor effort is described 
as suboptimal effort, nonoptimal effort, incomplete effort, biased responding, and/or negative 
response bias on performance-based tests.  Exaggeration, either over- or under-reporting, is 
described as faking, feigning, simulating, dissimulating, magnifying, and amplifying of thoughts, 
feelings, and/or behaviors on rating scales or in the clinical interview.  There is overlap between 
poor effort and exaggeration strategies, however, it is believed that a malingerer will select the 
most appropriate faking strategy depending upon the assessment.  For example, the easiest and 
most effective malingering strategy for a symptoms-only assessment would be to exaggerate 
symptom complaints on a rating scale, as opposed to displaying poor effort to complete a 
performance measure.   
Validity tests are used to assess both poor effort and symptom exaggeration.  Symptom 
validity tests (SVT) assess for exaggerated responses on rating scales.  One example of a SVT is 
an embedded validity scale within a rating measure (e.g., infrequency scale).  Performance 
validity tests (PVT) assess for poor effort or ability to perform a task.  For example, these can 
include standalone performance-based assessments (e.g., Word Memory Test), or cutoffs within 
existing cognitive measures (e.g., Reliable Digit Span).  Both are used as screening measures to 
alert a clinician to suspected cases of malingering.  As they are used for screening purposes, 
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SVTs and PVTs should demonstrate excellent specificity (~90%) to reduce false positive 
malingering classifications (Larrabee, 2012).  PVTs and SVTs with high face validity for the 
diagnosis have the highest probabilities for detecting malingering (Jasinski et al., 2011).  It is 
currently recommended that PVTs and/or SVTs be included in ADHD evaluations as they have 
been shown to be superior at identifying malingering in comparison to clinical judgment and 
rating scales alone (Booksh et al., 2010; Marshall et al., 2016).   
 Malingered ADHD in the College Population.  In the field of neuropsychology, 
malingering has often been associated with financial incentives (e.g., workers’ compensation, 
Social Security Benefits).  However, the pursuit of an ADHD diagnosis might be influenced by 
other incentives, such as medications and academic accommodations.  There has been a rise in 
rates of stimulant misuse on college campuses, with a recent meta-analysis estimating prevalence 
rates at 17% on college campuses (Benson, Flory, Humphreys, & Lee, 2015).  In addition, the 
literature indicates that a high percentage of college students positively associate stimulant 
medication with the ability to increase focus for academic tasks (Hartung et al., 2013; Lookatch, 
Dunne, & Katz, 2012).  Some college students report using stimulant medications for 
recreational purposes, and others sell the medication illegally (Lookatch et al., 2012; McCabe et 
al., 2005).  Contingencies such as medication serve as positive reinforcement that motivates 
some individuals to malinger.  Although exact numbers are unknown, malingering has been 
estimated to occur in as many as 22% to 47% of college-aged ADHD referrals (Marshall et al., 
2010; Sullivan et al., 2007).  A number of studies have investigated college students’ ability to 
malinger, the strategies that malingers use, and the ability of the current validity indicators to 
detect malingering.   
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One of the first studies on malingered ADHD in college students was conducted by 
Quinn (2003) who investigated the ability of college students to fake symptoms on a commonly 
used rating scale—the ADHD Behavior Checklist (Murphy & Barkley, 1996b).  Data were 
collected from three groups.  The clinical ADHD group consisted of college students with a 
clinical diagnosis of ADHD.  The non-ADHD control and malingering groups consisted of 
college students without a history of disability.  The ADHD group and non-ADHD control group 
were both instructed to respond and perform honestly across all measures.  College students in 
the malingering group were instructed to fake symptoms after reading a role-playing scenario in 
which they struggle academically and instructed to believe that medications/accommodations 
will help them.  The results revealed no discernible differences between the ADHD and 
malingering group on both Current and Retrospective self-report of Inattention and Hyperactivity 
(Quinn, 2003).  Overall, this study was the first to demonstrate that college students could easily 
fake ADHD symptoms with minimal preparation.   
Jachimowicz and Geiselman (2004) expanded the previous work of Quinn (2003) by 
examining college students’ ability to malinger ADHD on four different rating scales—the 
Wender Utah Rating Scale (WURS; Ward et al., 1993), the Conners’ Adult ADHD Rating Scale 
(CAARS; Conners, Erhardt, & Sparrow, 1998), the Brown Adult ADHD Scale (BAAS; Brown, 
1996), and the ADHD Rating Scale (ARS; DuPaul, Power, Anastopoulos, & Reid, 1998).  They 
randomly assigned 80 non-ADHD participants to fake ADHD on one of the four rating scales 
after studying the DSM-IV criteria for ADHD.  Corroborating previous findings, these college 
students without ADHD were successful in meeting the ADHD symptom threshold on all four 
measures.  Interestingly, malingering was largely associated with over-reporting hyperactivity-
impulsivity symptoms.  There was a higher likelihood of obtaining an ADHD diagnosis (false 
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positive rates) on the two measures that place a greater amount of emphasis on hyperactivity 
items (BAAS and CAARS).  In contrast, the WURS and the ARS place less emphasis on 
hyperactivity items and had lower false positive rates.  
Building upon previous research, Harrison, Edwards, and Parker (2007) investigated 
college students’ ability to malinger ADHD on the CAARS—a rating scale that was previously 
found to have a high risk for false positives (Jachimowicz & Geiselman, 2004).  This time, the 
researchers compared the responses from control and malingering groups to archival data of 
college students with ADHD.  This study found that college students instructed to malinger 
ADHD (malingering group) reported slightly higher symptom endorsement rates compared to 
the clinical ADHD group on the CAARS Inattentive, Hyperactivity, and ADHD Total scales.  
However, this higher endorsement rate was not at levels sufficient to significantly distinguish the 
malingering group from the clinical ADHD group.  This slight over-reporting relative to the 
clinical ADHD group has been confirmed in other studies (e.g., Harrison & Edwards, 2010).  
The findings suggest that given minimal information about ADHD, college students without 
disabilities can mimic symptom reports on rating scales that align with true ADHD symptom 
presentation.  Yet, the tendency for malingerers to slightly over-report symptoms creates the 
unanswered question of whether malingerers may also endorse exaggerated or unrealistic 
symptom items that are not frequently endorsed by those with ADHD.   
Several other studies have since confirmed the aforementioned findings that college 
students can deceive various ADHD rating scales with little to no preparation (Booksh, Pella, 
Sing, & Gouvier, 2010; Fisher & Watkins, 2008; Marshall et al., 2010).  Across studies, 
malingerers report slightly higher endorsements on ADHD symptom items, but again, these rates 
are not statistically different from those with true ADHD.  These studies also indicate that 
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malingerers exaggerate more on hyperactivity-impulsivity items in comparison to those with 
ADHD (Harrison et al., 2007; Harrison & Edwards, 2010; Jachimowicz & Geiselman, 2004) as 
well as those with ADHD with co-morbid diagnoses (Williamson et al., 2014).  Although the 
reason for malingerers to favor hyperactivity-impulsivity items is largely unknown, they are 
more observable than internalizing symptoms (i.e., inattention).  In fact, the general population 
has a tendency to implicate hyperactivity-impulsivity symptoms with an ADHD diagnosis 
(McLeod et al., 2007).  Thus, exaggerated hyperactive-impulsive items (e.g., run around the 
house), that would not be endorsed by true ADHD individuals, might be endorsed by 
malingerers. 
In addition to the hallmark symptoms of inattention and hyperactivity, ADHD is 
associated with functional impairment and executive functioning deficits (Barkley, Murphy, & 
Fischer, 2008).  Unfortunately, like ADHD symptom rating scales, functional impairment and 
executive functioning rating scales are also easily deceived by adults’ malingering ADHD.  For 
example, Marshall and colleagues (2016) reviewed archival data of adults with ADHD aged 17-
55, with approximately 80% of the sample between the ages of 17-30 and referred from a 
university mental health clinic.  They divided the sample into ADHD and suspected malingering 
groups identified using the Slick (1999) criteria, which are two or more PVT failures, or one 
PVT failure and one SVT failure.  Overall, the ADHD and suspected malingering groups had 
statistically similar responses on ADHD symptoms, executive functioning, and functional 
impairment rating scales.  Consistent with previous research, this study also suggested that 
suspected malingerers slightly over-report symptoms.  In addition, the malingering group also 
slightly over-reported executive functioning difficulties in comparison to the ADHD group.  Due 
to this tendency to over-report, the malingering group was more likely to exceed the manual’s 
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cut score reflecting impairment in this domain compared to the ADHD group.  Both groups 
reported similar levels of impairment, yet, more individuals in the ADHD group (41%) 
ultimately met the functional impairment criterion in comparison to the malingering group 
(31%).  These results suggest that assessments of ADHD symptoms, executive functioning, and 
impairment can be faked by individuals who are intentionally seeking an ADHD diagnosis. 
Sollman, Ranseen, and Berry (2010) also investigated malingered ADHD in a college 
sample.  They asked the additional question of whether the use of monetary incentives would 
impact college students’ motivation and ability to malinger symptoms on various ADHD 
assessments, a topic that had only been considered by two previous studies (Booksh et al., 2010; 
Fisher & Watkins, 2008).  To increase motivation to fake ADHD, the malingering group in the 
Sollman et al. study was informed that they would receive an additional incentive if they 
successfully obtained an ADHD diagnosis.  Similar to previous studies, the researchers found 
small differences between the ADHD group and the malingering group on both rating scales.  
Yet contrary to previous research that did not use incentives (e.g., Quinn, 2003), this study found 
that malingerers were just as successful in faking ADHD on performance validity tests, 
commonly viewed as a gold standard for accurate ADHD diagnosis (Sollman, Ranseen, & Berry, 
2010).  This research highlights the power of incentives in motivating college students to 
malinger ADHD, and supports the inclusion of an incentive in the current project, along with 
future malingering simulation studies.   
Overall, research has shown that college-aged students are able to feign ADHD 
symptoms on a symptom rating scale, and they achieved greater success when provided with a 
monetary incentive in simulation studies.  In addition, these studies suggest that malingerers tend 
to over-report ADHD symptoms, particularly hyperactivity symptoms.  Because clinicians rely 
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heavily on elevated symptom endorsement to determine presence of ADHD, clinicians cannot 
easily detect malingerers who report only slightly higher symptom endorsement to those with 
true ADHD.  Thus, there is a clear need to include symptom validity tests within symptom rating 
scales to detect valid and invalid performance.  
 Assessment of Malingered ADHD.  Research has demonstrated that current symptom 
rating scales are susceptible to false positives and are successfully feigned by college students.  
Although the added use of PVTs can improve ADHD diagnostic accuracy over clinical judgment 
and rating scales alone (Booksh et al., 2010; Marshall et al., 2016), some clinicians view PVTs 
as merely supplemental to rating scales and others do not use them at all (Musso & Gouvier, 
2014; Nelson et al., 2014).  Another way to validate responding is to embed an SVT within a 
rating scale, and some researchers have stressed the need for such validity indicators in ADHD 
evaluations (Musso & Gouvier, 2014; Tucha, Fuermaier, Koerts, Groen, Thome, 2015).  
Currently, there are few SVTs embedded in ADHD rating scales, and unfortunately, even fewer 
that have any capability to detect malingered ADHD.  
The CAARS is one ADHD rating scale that utilizes embedded validity scales.  One of 
these validity scales is the Inconsistency Index, which is used to determine whether a respondent 
answered similar items in a consistent manner.  For example, two items on impulsive behavior 
would be expected to be answered the same by a consistent rater. To investigate the use of the 
CAARS Inconsistency Index to detect malingered ADHD, Suhr and colleagues (2008) examined 
archival data of individuals with ADHD and those who gave noncredible performance on a PVT 
(suspected malingering group).  This study found that the CAARS Inconsistency scale had 
inadequate specificity to detect the suspected malingering group.  Results indicated that 
suspected malingers reported high rates of ADHD behaviors on the majority of ADHD items, but 
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were not “inconsistent” in their responses on target (consistency) items (Suhr et al., 2008).  For 
example, a suspected malingerer who reported a high endorsement rate on one impulsivity item 
was more likely to report a similar high endorsement on another impulsivity item.  Therefore, the 
CAARS Inconsistency Index is an ineffective measure of malingering. 
In addition, the CAARS manual advises that a T-score above 80 on the Hyperactivity 
and/or Inattention Scales could indicate symptom exaggeration.  Yet, Suhr and colleagues (2008) 
found this method also to be insensitive to detect the suspected malingering group.  In this study, 
over 50% of individuals across all three groups (ADHD, noncredible performance, and 
psychological control) received a T-score of 80 or above on the CAARS Inattention scale.  
Although a greater percentage of the malingering group had elevated T-scores >80 on the 
Hyperactivity Index, this was not at levels to effectively distinguish differences from the ADHD 
and psychological control groups.  Overall, this study demonstrated that these two CAARS 
validity scales are not reliable detectors of malingered ADHD (Suhr et al., 2008). 
The study by Suhr and colleagues (2008) supported the finding that malingerers tend to 
exaggerate more on hyperactivity items than individuals with ADHD (e.g., Jachimowicz & 
Geiselman, 2004).  In contrast, Barkley, Murphy, and Fischer (2008) indicated that inattention 
symptoms are more often endorsed by adults with ADHD.  Following this finding, Marshall and 
colleagues (2010) examined whether a significant discrepancy between self-report on the 
inattention items and a clinician’s behavioral observations could detect malingered ADHD.  This 
discrepancy strategy was applied to archival records of 268 ADHD assessments and 
demonstrated 86% specificity to rule-out true cases of ADHD, yet it only had 35% sensitivity to 
detect malingering (Marshall et al., 2010).  Therefore, it appears that inconsistencies between 
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clinical observations and reported ADHD symptoms are not able to separate true ADHD from 
malingered ADHD.   
Because ADHD symptoms alone are ineffective at separating true ADHD from cases of 
malingering, a better strategy might be to embed symptom validity items within self-report 
measures.  The Clinical Assessment of Attention Deficit-Adult (CAT-A; Bracken & Boatwright, 
2005) is an ADHD rating scale that includes an embedded validity scale designed to detect 
malingering, called the Infrequency scale.  The CAT-A Infrequency scale consists of 10 items 
that appear to be ADHD symptoms, but are only endorsed by 1 - 6% of the ADHD population.  
For example, one infrequency item used in this scale is “I work more energetically than most 
people.”  The CAT-A manual suggests that high endorsement on three or more of the 
Infrequency scale items indicate possible noncredible report (Marshall et al., 2010).   
It should be noted that the CAT-A was standardized on a relatively small sample (N = 369; 
ADHD n = 67), and lacks psychometric support for the Infrequency scale.  Marshall and 
colleagues (2010) found that by using the manual cutoff of three items on the Infrequency scale, 
this scale detected malingering with sensitivity of 58.33% at optimal specificity of 89.39%.  
Using a cutoff score of four or more items decreased malingering sensitivity rates to 36.11%, but 
improved the specificity to 96.97%.  Although, this infrequency scale only demonstrated 
moderate success rates to detect malingered ADHD, it is better than the other available validity 
scales (Marshall et al, 2010).  These findings provide some evidence for the use of an 
infrequency scale similar to the one on the CAT-A.  Nevertheless, more work is needed to 
develop a symptom validity test to detect malingering versus true ADHD with high sensitivity 
and specificity. 
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A pilot study by Suhr, Buelow, and Riddle (2011) examined an infrequency validity scale 
based on 12 items from the CAARS.  They used archival data and identified those with a score 
of 20 or less on 12 CAARS items that were endorsed infrequently (<10%) by individuals with 
ADHD, other psychological disorders, and general controls.  Overall, the authors reported that 
the created CAARS Infrequency Index (CII) could accurately classify suspected malingerers 
with 67% to 92% accuracy.  The CII demonstrated the best detection abilities for identifying 
over-report on the CAARS Hyperactivity Scale (T score >80), with 80% sensitivity at 93% 
specificity.  Yet, at excellent specificity levels (100%), the CII only had the sensitivity to detect 
30% of individuals who over-reported on the CAARS Inattentive scale.  Additionally, the CII 
lacked the ability to identify suboptimal performance on a PVT (24%) at 95% specificity levels.  
Although the CII demonstrated some promise in detecting malingering, the Suhr et al. 
(2011) study did have certain limitations.  The study was based on archival records with group 
assignment to ADHD and malingering groups based upon PVT performance.  Therefore, it is 
unknown whether suboptimal performances on the PVT were actual cases of malingering.  Also, 
this index only displayed adequate detection of over-report on ADHD Hyperactivity index, 
which is not a reliable malingered ADHD measure (e.g., Suhr et al., 2008).  To reexamine the 
utility of the CII, Fuermaier and colleagues (2016) conducted a simulation study in which 
college students were instructed to malinger ADHD.  They compared CII scores of the simulated 
malingerers to those of students with ADHD.  They found that the CII had only modest ability to 
detect the malingering group, with sensitivity of 32% at a modest 65% specificity level 
(Fuermaier et al., 2016).  Although these rates are better than clinical judgment and the use of 
rating scales alone, the findings from this study do not support the CII as a reliable indicator of 
malingered ADHD. 
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Outside of ADHD assessment, there are well-established validity scales that have 
demonstrated the ability to detect malingered psychopathology with high sensitivity and 
specificity rates.  One common assessment tool is The Personality Assessment Inventory (PAI; 
Morey, 1991) that includes several negative distortion validity scales.  The Negative Impression 
Management (NIM), Malingering Index (MAL), and the Rogers Discriminant Function (RDF) 
have demonstrated high sensitivity and specificity to detect feigned psychopathology using a 
cutoff T-score of 70 or above (Morey, 1991).  Several studies have analyzed the use of PAI 
validity scales to detect malingered ADHD.  Unfortunately, the research does not fully support 
the clinical utility of these scales to detect malingered ADHD.  To begin, two studies (Pella et 
al., 2012; Sullivan et al., 2007) using archival data found that those suspected of malingering 
rarely (<22%) exceeded the cutoff on the PAI validity indicators that would raise alarm to 
potential malingering.  Two simulation studies demonstrated greater detection rates for the RDF, 
an infrequency scale, but with only moderate specificity levels (Musso, Hill, Barker, Pella, & 
Gouvier, 2014; Rios & Morey, 2013).  The increased accuracy rates with the RDF provide 
evidence to support the use of an infrequency validity scale.  But the unreliable detection 
accuracy with the PAI validity indicators precludes its use to detect malingered ADHD.  
Recently, Harrison and Armstrong (2016) created an ADHD infrequency scale from the 
17 “pathological” items of the Dissociative Experiences Scale (DES; Bernstein & Putnam, 
1986), plus one additional item about academic functioning.  They reported that the DES items 
are related to inattention, but are infrequently endorsed by the general population.  These items 
were embedded into the CAARS and administered to undergraduate students seeking treatment 
(clinical archival data) and those not seeking treatment (simulation design).  This allowed for the 
comparison of two malingering groups (clinical Suspected Malingering and non-clinical 
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Simulated Malingering), two control groups (clinical Controls, and non-clinical Controls), and a 
clinical ADHD group.   
The results revealed that both Suspected and Simulated Malingering groups had a higher 
total score on these 18 items compared to the ADHD, and two Control groups. While the total 
sum of these items was able to accurately classify Honest reporting groups (85.3%), a significant 
proportion (75.3%) of Suspected/Simulated malingerers were also misclassified as Honest.  
ANOVA analyses revealed five candidate items from the DES with the largest response 
differences between the ADHD and malingering groups.  To increase detection accuracy, the 
researchers created an Exaggeration Index comprised of eight validity indicators—the five best 
DES items, sum of the 18 DES items, and over-report (T score >80) on the CAARS Inattention 
and Hyperactivity Indexes.  On this created Exaggeration Index, failure on one or more of the 
validity indictors revealed moderate sensitivity (51%) at optimal specificity levels (88%; 
Harrison & Armstrong, 2016).  These results are mildly encouraging, but validation studies are 
needed prior to clinical application on this validity test. 
In conclusion, various validity scales have been examined as potential methods to 
determine who has ADHD and who is feigning the disorder.  The research provides some 
evidence for the use of an infrequency scale (i.e., CAT-A Infrequency scale; PAI RDF).  
Unfortunately, the available validity scales require further validation (e.g., CAT-A) or fall short 
of adequate sensitivity and specificity levels to detect malingered ADHD (i.e., CAARS 
Inattention, CAARS Hyperactivity, CII, PAI negative validity scales).  A successful infrequency 
scale would include items that seem to describe ADHD-type behaviors, yet are infrequently 
endorsed by those with ADHD, and frequently endorsed by those faking ADHD (Jasinski et al., 
2011; Tucha et al., 2015).  To date, no ADHD validity scale has accomplished this level of 
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detection.  Because the currently available scales are either ineffective, unreliable, or not 
validated malingering detectors, additional research is needed to pilot test validity items that are 
intentionally designed to obtain over-endorsement by malingered ADHD, but not for individuals 
with true ADHD. 
Purpose of the Present Study 
Over the past 15 years there has been an increase in both public awareness about ADHD 
and referrals for adult ADHD evaluations (Barkley, Murphy, Fischer, 2008).  It appears that 
incentives such as medication, academic support, and test accommodations might be generating 
some of this increased interest in obtaining an ADHD diagnosis.  In addition, these incentives are 
suspected to promote increased rates of faking through symptom exaggeration and noncredible 
performance on psychological tests.  It is also known that college students have a positive view 
towards the incentives that stem from an ADHD diagnosis (Lookatch et al, 2012; McCabe et al, 
2005).  This creates an atmosphere that increases the likelihood that a portion of self-referred 
college students will malinger ADHD symptoms to obtain these incentives (Musso & Gouvier, 
2014). 
Diagnosis of ADHD is based largely on symptom self-reports and clinical judgment 
(Musso & Gouvier, 2014; Nelson et al., 2014).  However, rating scales are subjective and easy to 
manipulate to obtain an ADHD diagnosis (Harrison et al., 2007; Jachimowicz & Geiselman, 
2004; Quinn, 2003; Sollman et al., 2010).  Unfortunately, clinicians often do not measure or 
account for functional impairment in the diagnostic process (Nelson et al., 2014).  As a result, 
clinicians may be susceptible to make false positive diagnoses, especially when they see 
themselves as advocates for the students.   
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There is a need for better measures and methods to diagnose ADHD accurately (Musso & 
Gouvier, 2014; Tucha et al., 2015).  Most ADHD rating scales include only a list of symptoms 
that are easily learned and often endorsed by non-ADHD individuals.  There are measures of 
functional impairment, but most are not specific to ADHD, are not included in ADHD symptom 
rating scales, and are not incorporated by clinicians in their evaluations.  In addition, the 
available validity scales lack adequate sensitivity and specificity to detect malingered ADHD.  
The literature suggests a need for a multidimensional measure that assesses for ADHD 
symptoms, functional impairment, and a validity indicator to detect malingered ADHD.  
The purpose of this study was to pilot test the effectiveness of a Multidimensional ADHD 
Rating Scale (MARS) designed to identify ADHD and detect malingering.  This measure 
included three groups of items: ADHD symptoms, functional impairment, and symptom validity.  
The ADHD items were based on the 18 ADHD symptoms from the DSM-5.  Functional 
impairment items were created and based from various impairment rating scales.  Symptom 
validity items were created to reflect exaggerated ADHD symptoms, yet could be infrequently 
endorsed by individuals with ADHD.  The goal of this new measure was to assist with the 
diagnosis of ADHD in adults by examining the presence and severity of ADHD symptoms, 
extent of functional impairment associated with the symptoms, and to provide a method to detect 
suspected cases of malingering (symptom validity).  The self-report measure was constructed to 
yield five indexes that could be used to make diagnostic determinations: ADHD Total symptom 
index, ADHD Inattention index, ADHD Hyperactivity-Impulsivity index, Functional Impairment 
index, and Symptom Validity index.  
In order to assess the diagnostic efficacy of the pilot instrument, the study formed 
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three groups of college students (those with an ADHD diagnosis, non-ADHD controls, and non-
ADHD students instructed to malinger).  First, the symptom validity items were subjected to a 
multi-step analysis to identify the candidate items for a pilot symptom validity index.  Next, 
group comparisons were examined for all index scores.  Lastly, this study conducted analyses to 
determine the classification accuracy for each index.   
 Group Comparison Hypotheses.  An aim of this study was to determine between-group 
comparisons for the primary MARS indexes: ADHD Inattention index, ADHD Hyperactivity-
Impulsivity index, ADHD Total index, Functional Impairment index, and the Symptom Validity 
index.  
ADHD Symptom Indexes. The first set of group comparison hypotheses surrounds the 
three ADHD symptom indexes.  For the Hyperactivity-Impulsivity index (H-index), it was 
predicted that the Malingering group would report a significantly higher score compared to the 
ADHD group.  It was hypothesized that both Malingering and ADHD groups would have 
significantly higher total H-index score compared to the Control group.  For the Inattention index 
(I-index) and ADHD Total index, it was expected that there would be no significant differences 
between the Malingering and ADHD groups.  Yet, it was expected that the Malingering and 
ADHD groups would be significantly higher on both ADHD Total index and I-index scores 
compared to the Control group.  
Functional Impairment Index. It was predicted that the Malingering group would report 
a significantly higher Functional Impairment index (FI-index) score compared to the ADHD 
group.  It was hypothesized that both the Malingering and the ADHD groups would have a 
significantly higher FI-index score compared to the Control group.   
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Symptom Validity Index.  It was hypothesized that the Malingering group would have a 
significantly higher Symptom Validity index (SV-index) score compared to the ADHD group 
and Control group.  It was predicted that the ADHD group would have a significantly higher SV-
index score than the Control group.   
Classification Accuracy Hypotheses.  The final aim of this study was to conduct 
preliminary analyses on the classification accuracy of the five indexes.  It was predicted that the 
SV-index would have sensitivity greater than 58% to detect the Malingering group and 
specificity rates greater than 89% to not identify the ADHD and Control groups.  These rates 
were derived from the best available ADHD validity indicator found in the CAT-A (Marshall et 
al., 2010).  It was also predicted that this pilot SV-index would have superior accuracy, 
predictive power, sensitivity, and specificity to detect malingering compared to the four ADHD 
indexes’ ability to diagnose true ADHD. 
Method 
Participants  
This study recruited participants with and without ADHD between the ages of 18-26. 
G*Power was used to calculate an a priori sample size for the between-group comparisons for 
small effect sizes (.25-.30).  With this effect size range, an estimated total sample size of 111-159 
was needed to achieve a power of .80. 
ADHD group.  The ADHD group was recruited by invitation letters and publically 
posted flyers (Appendix A and B).  The eligibility criteria were that participants have a 
professional diagnosis of ADHD and be between the ages of 18-26 (i.e., “college-aged”).  
Between October 2014 and March 2015, the Syracuse University’s Psychological Services 
Center (PSC) was used as the sole recruitment site.  However due to low referral number from 
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the PSC (n=4), recruitment was expanded to other sites and professional contacts.  Between 
March 2015 and May 2016, 77 individuals initiated contact for more study information as a 
result of the study flyer/letter.  Of those contacts, 43 elected to complete the phone screening.  
Participants reported the following recruitments sites: Syracuse University (n= 32), professional 
contacts (n=7), Virginia Department of Rehabilitative Services (n =2), and SUNY Cortland (n 
=2).  From the phone screening, 37 individuals were found eligible to participate in the study.  
The reasons for ineligibility were: No diagnosis of ADHD (n=4), no evidence of impairment 
(n=2), and a complicated medical/diagnostic history (n=1).  Two participants who were found 
eligible did not complete the online survey.   
Of those found eligible (n = 41), 39 participants completed the online study materials. 
This included 17 males (43.6%) and 22 females (56.4%) with an average age of 20.74 (SD=2.62) 
years.  The range was 18-27 for this group.  The 27-year-old participant was retained as she was 
recruited at the age of 26.  All participants self-reported a primary diagnosis of ADHD.  Nineteen 
(48.7%) reported at least one comorbid disorder.  The co-morbid diagnoses included learning 
disability (n=5, 12.8%), depression (n=7, 17.9%), anxiety (n=11, 28.2%), and bipolar disorder 
(n=1, 2.6%).  
Non-ADHD Groups.  The two non-ADHD groups were comprised of undergraduate 
students in an introductory psychology class.  In total, 147 participants were assigned to the 
Control (n=74) and Malingering (n=73) groups.  Of the 73 participants in the Malingering group, 
17 were removed from the analyses for the following reasons: Self-reported ADHD diagnosis on 
the demographic survey (n=6), missing data (n=4), admission of poor study effort (n=2), and 
extreme outliers on the ADHD indexes (n =5).  The Malingering group (n=56) included 26 males 
(46.4%) and 30 females (53.6%), with an average age of 18.79 (SD=1.00) years. Five 
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participants self-disclosed disabilities: Learning disability (n=1, 1.8%), hearing impairment (n=1, 
1.8%), depression (n=1, 1.8%), anxiety (n=1, 1.8%), and depression/bipolar disorder (n=1, 
1.8%).  
Of the 73 Control participants, 11 were removed for the following reasons: Incomplete 
data (n=1), not meeting study age criteria (n=1), self-reported ADHD diagnosis (n=1), no 
response to effort question on the exit survey (n=1), failing at least one “catch” item (n=6), and 
identified as extreme outlier on the ADHD indexes (n=1).  The Control group (n=62) included 
31 males (50.0%) and 31 females (50.0%) with an average age of 19.05 (SD=1.03).  Four 
students reported the following disorders: Depression, anxiety, depression and anxiety, and 
bipolar disorder. Additional group demographic information, including ADHD symptom 
presentations at two different cutpoints, is summarized in Table 1.   
Group characteristic analyses.  Chi-square tests were used to explore whether the three 
groups exhibited significant differences on the demographic categories of sex, ethnicity, year in 
school, and reported first language (English/other).  There was no significant difference between 
the groups on sex, χ²(2, n = 157) = .41, p = .81. There was a significant difference between the 
groups on year in school, χ²(10, n = 157) = 45.16, p <.001, and first language χ²(2, n = 157) = 
10.28, p =.006.  A one-way analysis of variance also revealed a significant difference between 
groups on age, F(2, 136) = 18.19, p < .001.  
Due to the significant differences in year in school, age, and language between the three 
groups, additional analyses were used to explore whether there were significant differences 
between the two non-ADHD groups (Control and Malingering) on these and other variables (i.e., 
disorder status, school problems, medication use, and stimulant use).  A Bonferroni correction 
was implemented and resulted in an alpha of .05/6 = .008.  The chi-square test revealed no 
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significant difference between the non-ADHD groups on year in school χ²(3, n = 118) = 2.61, p = 
.46.  There also was no significant age difference between the Control and Malingering groups, 
F(1, 98) = 1.61, p = .21.  These analyses revealed that the ADHD group had a larger proportion 
of older, more educated students in comparison to the non-ADHD groups.  It is suspected that 
the use of different recruitment methods for the ADHD (i.e., professional contacts) and non-
ADHD groups (i.e., undergraduate psychology course) contributed to these group differences 
between age and year in school.   
There was a significant difference between the non-ADHD groups on first language 
learned χ²(1, n = 118) = 9.27, p =. 002, with a higher percentage of other first languages reported 
in the Control group (19.4%) in comparison to Malingering group (1.8%).  Additional chi-square 
analyses revealed no significant differences between these two non-ADHD groups on sex χ²(1, n 
= 118) = .15, p =.70, disability status χ²(6, n = 106) = 3.49, p = .75, school problems χ²(1, n = 
117) = .28, p = .60, medication χ²(1, n =118) = .035, p = .85, or stimulant use χ²(1, n =118) = .01, 
p = .92.  Subsequent analyses revealed that age and year in school were not significant covariates 
on the majority of MARS indexes.  However, as discussed in the results section, language was 
found to be a significant covariate on the FI-index.   
Materials  
Multidimensional ADHD Rating Scale (MARS).  The MARS is divided into three 
components:18 ADHD symptom items listed in the DSM-5, 104 pilot symptom validity items, 
and 22 functional impairment items.  A team of ADHD professionals generated the symptom 
validity items.  The items were based upon exaggerated examples of DSM-5 ADHD symptoms. 
The MARS also contained three “catch” items (e.g., “respond 3 if you are still reading this 
survey”) embedded in the scale to assess for effort and attention to the survey.  Section one 
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contains the 18 ADHD symptoms (#1-18) and the pilot symptom validity items.  Section two 
contains the functional impairment index.  These 147 items (plus additional Sluggish Cognitive 
Tempo items not included in this study) are located in Appendix C.   
All items used a 9-point Likert response scale.  This is based upon research that indicated 
optimal validity, reliability, and discriminative power is attained using >5 response choices on a 
scale (Preston & Colman, 2000).  For all MARS items, five response labels were equally spaced 
on a 0-8 numeric scale.  The first section with the ADHD symptoms, SV-items, and Sluggish 
Cognitive Tempo items (not included in the present study) used a frequency scale, with the labels 
0=Never, 2=Rarely, 4=Sometimes, 6=Often, and 8=Very Often.  The functional impairment index 
used a severity scale, with the labels 0=Not at All, 2=Somewhat, 4=Mild, 6=Moderate, and 
8=Severe.  
Five index scores were formed from the MARS items.  The ADHD Inattention index (I-
index) was composed of the total score of nine ADHD inattention symptom items, with a 
maximum total score of 72.  The ADHD Hyperactivity-Impulsivity index (H-index) was 
composed of the total score of nine ADHD H-items, with a maximum total score of 72.  The 
ADHD Total index was the sum of all 18 ADHD symptom items, with maximum total score of 
144.  The Functional Impairment index (FI-index) was composed of the total score of the 22 
functional impairment items, with maximum total score of 176.  The final SV-index consisted of 
seven items, with a maximum total score of 56.   
To provide additional characteristics of the sample, the three DSM 5 ADHD presentations 
were determined using the ADHD inattention and hyperactivity-impulsivity items at two 
different cutpoints.  First as the midpoint is traditionally used to signify elevated responses on 
commonly used ADHD rating scales (e.g., BAARS, CAARS), elevated responses were defined 
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as a response higher than the response scale midpoint (≥ 4).  Second, because DSM-5 indicates 
that ADHD symptoms must occur “often,” scores ≥ 6 (Often) were used as another cutpoint.  To 
meet the Inattentive presentation symptom criterion, an individual needed to have elevated 
scores above each cutpoint on at least five ADHD inattention items.  An elevated score above 
each cutpoint on at least five ADHD hyperactivity-impulsivity items qualified for Hyperactive-
Impulsive presentation symptom criterion.  The Combined presentation occurred when an 
individual met the symptom criteria for both Inattentive and Hyperactive-Impulsive 
presentations. 
ADHD Screening Form.  A screening form was used to verify ADHD diagnosis and 
study eligibility for individuals recruited outside the PSC.  The focus of the screening questions 
was to verify ADHD diagnosis, symptoms, and impairment (Appendix D).  Individuals met 
study eligibility if they a) had a diagnosis of ADHD, b) received the diagnosis from a qualified 
professional (e.g., psychologist, counselor), c) symptoms occurred before the age of 12, d) they 
currently experience symptoms, and e) reported impairment in at least one area (i.e., academic, 
occupational, or social).  Additional information was collected, including age of diagnosis, but 
this was not used as a factor to determine study eligibility.  
Demographic Questionnaire.  Individuals completed a brief demographic questionnaire.  
Questions asked a) age, b) gender, c) ethnicity d) year in college, e) GPA, f) diagnosis, g) 
accommodations in college, h) medication, i) use of stimulant medication and j) school problems 
(Appendix E).   
Exit Survey. Individuals completed an exit survey inquiring about his/her experience 
completing the self-report measure.  All participants answered questions about previous ADHD 
knowledge.  In addition, all participants were asked about effort and whether they adhered to the 
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assigned study protocol (honest or malinger).  The ADHD and Control exit survey can be found 
in Appendix F.  The Malingering group responded to additional items about strategies that they 
used during the self-report measure to successfully fake ADHD (Appendix G).   
Debriefing Letter.  In order to increase effort, the Malingering group was informed at 
the beginning of the study that they needed to successfully fake ADHD to receive an incentive 
($100 Visa gift card raffle drawing).  The debriefing letter provided at the end of the study 
informed them that all participants who completed the study, regardless of effort, would be 
entered into the raffle drawing (Appendix H). 
Procedures 
 ADHD Group.  All data were collected via an online survey system.  The online system 
presented the ADHD symptom and symptom validity items in random order.   Eligible 
individuals with ADHD independently completed the online survey sent via email.  After 
reviewing and signing the electronic informed consent (Appendix I), individuals completed the 
demographic questionnaire.  Prior to completing the MARS, the ADHD group received written 
instructions to complete the MARS honestly, and additional instructions for those receiving 
treatment (e.g., medication) to answer items as if they were not receiving treatment.  They then 
proceeded to complete the two sections of the MARS, followed by the exit survey.  They were 
instructed during the phone screening to contact the researcher after completing the study to 
verify mailing address and to ensure timely receipt of the cash compensation. 
 Non-ADHD Groups.  To reinforce adherence to group procedures, non-ADHD 
participants were administered the study via in-person group sessions.  Both groups began by 
reviewing the informed consent (Appendices J and K) and the purpose of the study.  After 
electronic consent was obtained, both groups completed the demographic questionnaire.  Next, 
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participants were provided with the verbal and written instructions based upon his/her group 
assignment.  The Control group received instructions to respond honestly on the MARS self-
report measure.  The Malingering group received instructions to complete the MARS by faking 
the symptoms and diagnosis of ADHD.  Additionally, they were informed that those who faked 
ADHD would be entered into a raffle drawing for a $100 gift card.  To assist them, this group 
was provided with an instructional packet with a short case scenario adapted from Sollman and 
colleagues (2010) that described why an individual would want to malinger ADHD.  The 
remainder of the Malingering instructional packet contained information about the symptoms 
and long-term prognosis of ADHD.  This information was adapted from WebMD ADD & 
ADHD Health Center website (Appendix L).  Participants were provided 5 minutes to review the 
malingering instructional study packet.  After time had elapsed, the Malingering group returned 
the study materials to the researcher and completed the MARS.  Next, all participants completed 
the appropriate exit survey.  After completing the exit survey, the Malingering group participants 
were provided with the debriefing letter. 
Incentives.  Incentives were offered to each participant to assist with study recruitment as 
well as increase motivation and effort. The Control and Malingering group received 1 credit hour 
through Sona Systems towards his/her psychology coursework requirement.  The ADHD group 
received $20 cash or 1 credit hour through Sona Systems for completing all study materials.  
Both of these incentives were allocated on a continual basis.  All three conditions were also 
entered into a raffle drawing of $100 Visa gift card for completing the study materials.  The 
raffle occurred in May 2016.   
 Procedural Integrity.  Researcher adherence to the Control and Malingering condition 
protocols was verified with the procedural script (Appendices M and N).  The primary researcher 
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checked off the boxes after each step was completed.  A research assistant was present to assist 
with procedural integrity and administration of the protocol in 8 of 22 (36%) sessions.  The 
procedural integrity for these eight sessions was 100%. 
Research Design and Statistical Analyses 
Similar to previous studies, the current study used a three-group research design.  To 
reduce the quantity of symptom validity items, possible items were subjected to infrequency and 
mean difference analyses.  This methodology (described fully below) resulted in a small set of 
SV items that had the most potential to distinguish ADHD from Malingering cases.  The next set 
of analyses involved between-group comparisons on the five total index scores.  The dependent 
variables were the total raw score for each of the five indexes.  Five separate omnibus tests 
analyzed the between-group differences for each index.  Across omnibus and post-hoc 
procedures, Bonferroni corrections were utilized to control for the effect of repeated contrasts, 
resulting in an alpha of .01.  Omega squared (ω2) was calculated to provide a less biased and 
more conservative effect size estimate.   
Next, receiver operating characteristic (ROC) analyses were conducted to determine each 
of the five index’s ability to predict two criterion variables.  Five separate ROC analyses were 
used to predict cases of ADHD between ADHD and Controls.  Five ROC analyses were used to 
identify cases of malingering between ADHD and Malingering groups. For all ROC analyses, 
the predictor test was one of the five index scores.   
The ROC analyses included Area Under the Curve (AUC) and graphical plots of 
sensitivity and (1-specificity) at each cutpoint. An AUC of 1.0 is considered a perfect test, while 
an AUC of .50 is no better than chance (50%).  Although there are several different ways to 
establish cutpoints (Youngstrom, 2013), this study identified two thresholds of optimal 
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sensitivity (~90%) and optimal specificity (~90%).  These optimal thresholds provide two 
important data points about the instrument’s ability to classify true positives and true negatives.  
For three self-report symptom indexes and one impairment index, the goal was to detect as many 
true ADHD positives (sensitivity) that may warrant additional assessments.  For the symptom 
validity index, the goal was to correctly identify cases of suspected malingering, but not classify 
true ADHD (specificity; true negatives for malingering).  From both optimal sensitivity and 
specificity cutpoints, correct classification rates were computed to present the proportion of true 
positive and true negative cases compared to the whole sample.  Furthermore, positive predictive 
power (PPP) and negative predictive power (NPP) were calculated to provide information on the 
probability that the test outcomes are accurate.  In other words, whether an individual truly has 
the diagnosis with a positive test result (PPP), and does not have the diagnosis with a negative 
test result (NPP).  However, as NPP and PPP are dependent upon base rate, NPP and PPP were 
calculated with the study’s base rate of malingering (58.9%) and ADHD (38.6%), along with the 
estimated population base rate of adult ADHD (5%; DuPaul et al., 2004), and a median 
malingering base rate estimate (30%; Suhr et al., 2008) obtained from research. 
Results 
Data Preparation 
Data input and consistency checks.  The primary researcher was responsible for 
downloading the online information.  Initially, the data were downloaded into a Microsoft Excel 
spreadsheet, organized, and then transferred to SPSS for data analysis.  All information was 
examined to verify quality of the data.  As previously reported, data were analyzed to verify age 
eligibility, group membership (e.g., ADHD diagnosis), failure to complete the study, response 
bias and catch item failures.  Additionally, extreme outliers in the Control (n=1) and Malingering 
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groups (n=5) on the ADHD symptom indexes and FI index were removed from the data set.  
Twenty-four participants had one occurrence of a missing value within one of the indexes.  As 
these missing values would depreciate the dependent variable (index total score), missing values 
were replaced with the mean for the given participant’s index (Kantardzic, 2003). 
Assessing Assumptions.  In preparation for the omnibus tests, data were assessed for 
covariates, outliers, skewness, kurtosis, and homogeneity of variance.  First, the MARS indexes 
were re-examined for outliers.  A 90% Winsorization method was used on the seven outliers 
remaining in the three groups on the ADHD I-index, ADHD H-index, FI-index, and the final SV-
index (Howell, 2010).  The ADHD Total index was calculated with the sum of the winsorized 
ADHD I-index and ADHD H-index.  Afterward, normality for each index was assessed by 
examining Q-Q plots, histograms, skewness, and kurtosis.  All indexes were found to have 
skewness and kurtosis <1.0.  Next, covariates were investigated for the five indexes.  Age, sex, 
and language were not found to be significant covariates on the ADHD symptom indexes and 
SV-index.  Therefore, one-way analyses of variance (ANOVA) were used on the ADHD 
symptom indexes and the SV-index.  Levene’s F test revealed the assumption of homogeneity of 
variance was violated for these analyses.  As a result, the Welch (1951) adjusted F ratio is 
reported for these ANOVA analyses.      
Although sex and age were not significant covariates on the FI-index, language was 
found to be a significant covariate, F (1, 152) = 4.08, p = .045.  This was related to a significant 
relationship between impairment levels and first language in the Control group only (ρ = .32, p = 
.011).  To further investigate the nature of this covariate, the FI-index was subjected to multiple 
analyses with similar findings.  Two separate ANOVAs with and without other first language 
speakers both indicated significant differences between the groups. An ANCOVA determined 
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that language differences had a small effect (η2  = .03) on FI-Index score.  Because of the similar 
findings and negligible effects of language, only the ANOVA group comparisons with all 
language speakers are reported.  Due to the multiple comparisons, including the multiple FI-
index comparisons, a Bonferroni correction was applied (⍺. = .05/8 =.006). 
Creation of the Symptom Validity Index   
 Prior to conducting group comparison analyses, the first aim of this study was to 
compose a Symptom Validity index (SV-index).  The original 104-item pool was developed via 
an expert consensus meeting. This item pool was then reduced to those items that would best 
discriminate malingerers from true ADHD cases.  To do this, the SV-items were subjected to 
infrequency and mean difference analyses. First, SV-item means were analyzed to identify those 
items that were infrequently endorsed (≤ 2) in the ADHD and Control group yet frequently (≥ 5) 
endorsed in the Malingering group.  This reduced the item pool from 104 items (Table 2) to 11 
items (Table 3).  Next, the remaining 11 SV-items were analyzed to identify the items with mean 
differences ≥ 3.5 between the ADHD and Malingering groups. The final SV-index was 
comprised of the remaining seven items that were identified through both infrequency and mean 
difference analyses (Table 4).   
Index Characteristics 
Internal consistency was analyzed for all five indexes.  Cronbach’s alpha revealed 
excellent internal consistency for three indexes, I-index (⍺ = .92), ADHD Total index (⍺  = .93), 
and FI-index (⍺  = .95).  The internal consistency reliability for the H-index (⍺ = .87) and the 
SV-index (⍺  = .84) were lower, but remained within the acceptable range.  As expected in an 
ADHD rating scale, index intercorrelations were high (r = .82 to .92) between the I-Index, H-
index, and FI-index.  Additionally, ADHD-Total was highly correlated with the FI-index (r = 
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.87).  Lastly, the SV-index had high intercorrrelations (r = .80 to .91) with the ADHD symptom 
and FI-index. 
Group Comparison Analyses  
The mean scores for each index were compared across the three groups.  The five index 
mean scores and standard deviations for each group are presented in Tables 4-8.  In summary, 
the three ADHD symptom indexes, FI index, and SV-index analyses revealed statistically 
significant main effects; ADHD Total Index Welch’s F(2, 86.06) = 271.21, p < .001; ADHD I-
Index Welch’s F(2, 86.69) = 194.93, p < .001; ADHD H-Index Welch’s F(2, 84.35) = 229.90, p 
< .001; FI-Index Welch’s F(2, 86.96) = 88.71, p < .001, and the SV-index Welch’s F(2, 77.44) = 
184.14, p < .001.  Although it was predicted that significant differences would only be obtained 
on select indexes, post-hoc analyses (Games-Howell) found significant differences between all 
three groups across the five indexes. Consistent across the five indexes, the Malingering group 
had a significantly higher mean score in comparison to the ADHD and Control groups.  
Additionally, the ADHD group had a significantly higher mean score in comparison to the 
Control groups across all five indexes.   
To present less biased and more conservative effect sizes, omega squared (ω2) was 
calculated for each main effect and is presented in Table 8.  For the main effects, there were 
large effect sizes for all five indexes, ranging from ω2  = .52 - .73.  Larger effect sizes were 
obtained for the ADHD Total index and SV-index.  The smallest effect size was obtained on the 
FI-Index. 
Classification Accuracy Analyses and Calculations 
 A major aim of the study was to determine the classification accuracy for all five indexes 
to predict cases of ADHD and cases of malingering using ROC analyses and probability 
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calculations.  All five index scores were subjected to ROC analyses.  First, five ROC analyses, 
one for each index score, were conducted to identify cases of ADHD between ADHD and 
Control groups.  Next, five separate ROC analyses were conducted to discriminate malingerers 
between ADHD and Malingering groups.  Tables 9-13 present the sensitivity and (1-specificity) 
at each cutpoint of the five MAR indexes to identify cases of ADHD.  Table 14-18 presents the 
sensitivity and (1-specificity) at each cutpoint on the five indexes discriminating cases of 
malingering.  From the ROC analyses, cutpoints were identified at two different thresholds—
optimal sensitivity (~90%) and optimal specificity (~90%).  Tables 21-22 present additional 
calculations of the five indexes at these optimal thresholds.  This also includes correct 
classification rate, and calculations of positive predictive power (PPP) and negative predictive 
power (NPP) at two different base rates (current sample and estimated population base rates for 
ADHD and malingering).   
The accuracy of the index (AUC), standard error, and confidence intervals for each index 
discriminating cases of ADHD are presented in Table 19, and for cases of Malingering are 
presented in Table 20.  Tables 21-22 contain the classification accuracy calculations at optimal 
sensitivity and specificity cutpoints for identifying ADHD and Malingering, respectively. As 
expected, two of the ADHD symptom indexes (Total and I-index) both had the highest AUC 
(.84), showing high levels of accuracy to identify cases of ADHD from Controls.  However, 
although self-report measures traditionally rely upon sensitivity rates, the highest correct 
classification rate was obtained at the optimal specificity cutpoints on the ADHD H-index 
(80.2%) and ADHD Total index (80.2%).  Yet, this was predominantly correct classification of 
Controls, and at least a third of the ADHD group failed to exceed this higher threshold.  
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As predicted, the ROC analyses identified the SV-index as the best discriminator for 
cases of malingering (AUC = .95), including a classification rate of 88.4% at the optimal 
sensitivity cutpoint.  The remaining indexes also fell within good (>.80) to excellent (.90) AUC 
ranges for identifying significant over-report of malingerers.  Contrary to predictions, the 
classification accuracy calculations suggest that over-report on ADHD-H and/or ADHD Total 
index could be used as additional validity detectors for malingered ADHD.   
Additional Post Hoc Analyses  
Catch Item Failure.  The MARS three embedded “catch” items were identified as 
potential indicators to detect malingered ADHD.  The three catch items (i.e., “respond 3 if you 
are still reading this question”) were included to monitor effort and attention throughout the 
rating scale.  Interestingly, of the 56 Malingering participants, there was a significant percentage 
of failure on these items.  While no one in the ADHD group and only six Controls (9.7%) failed 
one catch item, well over one-third (39.3%) of the Malingering group failed at least one of these 
items.  In fact, 15 participants (26.8%) failed all three catch items.  In order to check for response 
differences, independent samples t tests were conducted between Malingerers who passed (n=34) 
and Malingerers who failed at least one catch item (n=22).  This revealed no significant 
differences between these two groups on any of the five primary indexes, ADHD Total index 
t(54) = -.73, p = .47, ADHD I-index t(54) = -.81, p = -.42, ADHD H-index t(54) = -.53, p = .60, 
FI-index t(54) = -.25, p = .80, and SV-index t(54) = .44, p = .66.  As there were no significant 
response differences between those who passed and failed the catch items, and none of these 
participants disclosed poor effort on the exit survey, it is suspected that this was an intentional 
“faking bad” or “carelessness” strategy to mimic the diagnosis of ADHD.  
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Discussion 
 The purpose of this study was to examine the characteristics of a newly constructed 
multidimensional ADHD self-report measure to jointly assess ADHD symptoms, functional 
impairment, and symptom validity.  The aim of the new measure was to accurately classify true 
cases of ADHD and detect cases of malingering.  The three ADHD symptom indexes were based 
on the 18 ADHD symptoms in the DSM 5.  The Functional Impairment index (FI-index) 
consisted of newly constructed set of 22 impairment items.  The Symptom Validity index (SV-
index) consisted of seven items identified from a pool of 104 exploratory symptom validity 
items.  Reliability analyses revealed all three ADHD symptom indexes, the Functional 
Impairment index, and Symptom Validity index had adequate internal consistency.  The analyses 
indicated that all items could be retained to maintain this internal consistency.  Although this is 
an expected finding for the DSM 5-based ADHD symptom indexes, this is an important finding 
in support of the new items contained within the created FI-index and SV-index.   
Although it was predicted that malingerers would respond at statistically higher levels on 
only three indexes, the results indicated that across each of the five indexes, they endorsed items 
at significantly greater levels than those with ADHD and Controls.  As predicted, both the 
ADHD and Malingering groups endorsed more symptoms and impairment than controls.  Yet, 
even though malingerers endorsed more problem severity than those with ADHD, the traditional 
use of a lower cutpoint to detect clinical ADHD would also misclassify cases of malingering as 
“true” ADHD.  In other words, malingerers were rather successful at exceeding the symptom and 
impairment threshold that was needed to discriminate ADHD from controls.  This supports the 
need for a validity test to detect the exaggerated responding associated with malingering.  The 
findings provide support for the newly created SV-index, which demonstrated better 
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classification than the best available validity indicator (i.e., CAT-A).  Additional ROC analyses 
and associated diagnostic accuracy calculations demonstrated that a higher cutpoint on the 
ADHD symptom indexes could also provide an additional tool to detect cases of ADHD from 
controls and malingerers.  
Detection of ADHD 
Traditional ADHD self-report measures place an emphasis on sensitivity rates, or the 
ability to accurately identify potential cases of ADHD for further assessment.  Yet aligning with 
previous research (DuPaul et al., 2014), this study found high rates of ADHD symptom 
endorsement in the Control group.  This high endorsement rate led to a significant proportion of 
Controls (46.8%-61.3%) misclassified on the ADHD symptom indexes.  The classification 
accuracy calculations indicated that higher correct classification rates occurred at optimal 
specificity levels, yet not sensitivity levels.  However, the correct classification was primarily of 
controls, with over one third of ADHD participants misclassified with the higher specificity 
cutpoint.  Therefore, the overall results align with recommendations to adopt a cutpoint that 
maximizes sensitivity to detect ADHD symptoms on self-report rating measures.  This also 
underscores that a symptoms-only assessment results in false positive ADHD diagnoses (e.g., 
DuPaul et al., 2014).  To increase diagnostic accuracy, evaluators should consider all DSM 5 
diagnostic criteria for ADHD, including impairment and differential diagnoses (e.g., Gathje, 
Lewandowski, & Lovett, 2008). 
Research strongly supports the joint assessment of symptoms and impairment (e.g., 
American Academy of Pediatrics, 2011; DuPaul et al., 2014).  However, the pilot FI-index was 
not an effective discriminator of clinical ADHD from Controls.  Similar to the ADHD symptom 
indexes, a significant proportion of the study’s Control group (66%) exceeded the study derived 
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impairment cutpoint.  But this low cutpoint was established because the ADHD group reported 
few domains of impairment.  This low endorsement of impairment could be attributed to the 
characteristics of the study’s small clinical sample, comprised of older, more educated 
individuals compared to controls.  Additionally, low self-reported impairment report could 
reflect the positive illusory bias found in this clinical population (Prevatt et al., 2012).  As this is 
a pilot study on a newly created measure, more research is needed on larger and more diverse 
samples (e.g., non-university populations) to determine effective ADHD symptom and 
impairment thresholds.  Therefore, it is recommended that clinicians still follow best practice 
guidelines to assess both symptoms and impairment.  Additional considerations of differential 
explanations (e.g., year in school, culture, malingering) are also recommended in order to 
effectively diagnose ADHD.  
Ease of Malingering 
 In general, the results support the research that college students fake ADHD by over-
reporting on ADHD symptom and impairment items (e.g., Harrison et al., 2007; Marshall et al., 
2016; Quinn, 2003).  Whereas prior research typically reported non-significant differences 
between the groups, this study found that malingerers over-reported symptoms and impairment 
at significantly higher levels than students with ADHD.  To explain the different outcomes of 
this study, the MARS scale has an expanded 9-point response scale.  As previous malingering 
research relied upon ADHD rating scales with only 3-5 response choices, this may have created a 
restriction-of-range effect, which reduced the magnitude of group differences (Booksh et al., 
2010; Preston & Colman, 2000).  Thus, it is possible that the MARS scale was able to detect 
group differences because it used a more sensitive scaling approach.  The results of this study 
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provide support for the use of expanded response scales to achieve optimal reliability, validity, 
and discriminative abilities with rating measures (Preston & Colman, 2000).  
 The study’s findings also support the need for a symptom validity test to detect 
malingered ADHD.  The Malingering group significantly over-reported symptom and 
impairment levels in comparison to the ADHD group. As a result, all Malingering participants 
exceeded the sensitivity cutpoints of all ADHD symptom indexes and FI-index that were 
identified to detect clinical ADHD.  This confirms prior research (e.g., Marshall et al., 2016, 
Quinn, 2003) demonstrating that college students can easily simulate ADHD symptoms and 
impairment on rating scales. With suspected malingering base rates as high as 22-47% on college 
campuses (Marshall et al., 2010; Sullivan et al., 2007), there is a clear need to have a symptom 
validity index able to detect this population. 
Detecting Malingering 
Symptom Validity Index.  The SV index was comprised of seven items that maximally 
separated the ADHD and Malingering groups.  ROC analyses on this index led to good 
classification accuracy (83.2% and 88.4%) at identifying the malingerers at optimal levels of 
sensitivity and specificity, respectively.  This SV-index demonstrated better classification rates 
than any available validity scale, including the CAT-A Infrequency index (Marshall et al., 2010) 
and the new Exaggeration Index (Harrison & Armstrong, 2016).  Research (e.g., Tucha et al., 
2015) has suggested that available scales are not very effective at detecting malingering, because 
they either utilize actual ADHD symptoms, lack face validity, or do not measure feigned ADHD 
well.  The present study deliberately created items that have face validity via an expert consensus 
meeting.  That is, the items could be logically associated with other ADHD behaviors yet be 
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infrequently endorsed by those with ADHD.  This process seemed to result in a more reliable 
and discriminating validity scale. 
Of the seven SV-items, all are based on externalizing behaviors of ADHD.  Perhaps these 
behaviors are more easily observed and recognized, and thus more readily endorsed by non-
ADHD malingerers.  Or, these items may be more easily associated with a stereotype of ADHD, 
or the public’s conceptualization of what characterizes ADHD.  The general population is not 
well informed about ADHD, with many relying upon television and popular media as their 
primary sources of information (Bussing et al., 2012; McLeod et al., 2007).  If this is the case, 
malingerers could be generalizing from things they hear that then lead to misconceptions or 
stereotypes about ADHD, and so they over-endorse items that they think are symptoms of 
ADHD.  
All seven items in the final SV-index are related to symptoms of hyperactivity-
impulsivity.  This is in line with prior research that demonstrates malingerers tend to over-
endorse hyperactivity items when trying to feign ADHD (e.g., Marshall et al., 2010; Suhr et al., 
2008).  Research has indicated that the general population has a tendency to associate 
hyperactivity-impulsivity behaviors with ADHD (McLeod et al., 2007).  Yet, this public 
perception that ADHD is more closely related to hyperactivity is counter to the actual symptom 
endorsement of adults with ADHD, which tends to favor inattentive symptoms.  In the current 
study, the clinical ADHD group had higher endorsement of inattention symptoms compared to 
hyperactivity items.  In fact, the ADHD group’s mean was 10 points higher on the Inattention 
index in comparison to the Hyperactivity-Impulsivity index.  This, however, could be related to 
sample characteristics of the ADHD group.  Yet, prior research has found that adults with 
ADHD report more elevated inattention symptoms compared to hyperactivity items (Barkley, 
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Murphy, Fischer, 2008).  The tendency of ADHD malingerers to over-endorse hyperactivity-type 
items is certainly an issue worth pursuing in further research.  
Interestingly, two of the SV items involved socially inappropriate behaviors of running 
(i.e., SV29 and SV60).  Anecdotally, this is an activity that one sometimes sees with children, 
but very rarely with adults, including adults with ADHD.  Therefore it is possible that behavioral 
observations of ADHD children have led malingerers to believe that these behaviors also occur 
in adulthood.  Yet these assumptions are based upon observational evidence.  At this point, it is 
unclear why malingerers endorse behaviors that reflect over-activity.  
Interestingly, one of the six SV items involves driving abilities.  Apparently, some 
malingerers have the perception that those with ADHD are inattentive and impulsive drivers.  
Research has found that individuals with ADHD demonstrate inattentive and impulsive driving 
behaviors that increase their risk for traffic violations and vehicular crashes (see Barkley & Cox, 
2007).  Therefore, the malingering group may have some knowledge or experience that created 
the notion that individuals with ADHD are poor drivers.  In contrast, the students with ADHD in 
this study had a relatively low mean score on the FI index with regard to driving performance.  
So it appears that malingerers believe people with ADHD are poor drivers, whereas individuals 
with ADHD do not see themselves that way.  Interestingly, this tendency to under-report general 
driving impairment is documented in another study, and could be attributed to the positive 
illusory bias (Prevatt et al., 2012).  It appears that individuals with ADHD tend to report less 
significant driving problems than the general population actually perceives, and subsequently 
malingerers may use these perceptions to fake the symptoms of ADHD.  
One SV item includes a target word (“fidget”) that is listed among the DSM 5 symptom 
criteria.  It is possible that malingerers tended to endorse this item because the word cued the 
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individual’s memory for the specific DSM 5 symptom.  In fact, the Malingering group also 
highly endorsed another pilot SV-item that included the word “fidget” (see Table 3).  As has 
been discussed, the best malingering indicators have high face validity with behaviors that are 
associated with a target population, in this case ADHD (Jasinski et al., 2011).  This suggests that 
the use of DSM 5 specific words may increase face validity of the symptom validity items, and 
ultimately may increase the ability to detect cases of malingering.   
In regards to the other two SV items (i.e., SV32 and SV56), it is not clear as to why these 
specific items were retained in the SV index.  It is suspected that malingerers in this study 
endorsed these items because they fit the stereotype of people who cannot inhibit their 
movements.  In fact, the central theme of the SV-items seems to be lack of control of some motor 
behavior.  It would seem that such behaviors (and test items) warrant special attention in any 
research on the detection of malingered ADHD. 
 Symptom Over-report Indexes. The higher rates of symptom endorsement by the 
Malingering group compared to the ADHD group suggest that over-report on these indexes 
could be used as an additional validity indicator.  Specifically, the H-index and ADHD Total-
index were effective discriminators of both Malingering and ADHD.  Although this aligns with 
research that malingered ADHD tends to over-report hyperactivity symptoms (e.g., Jachimowicz 
& Geiselman, 2004), the findings are in opposite to research demonstrating the unreliable use of 
over-report cutscores on the CAARS symptom indexes (e.g., Suhr et al., 2011).  It is possible 
that the expanded Likert scale improved the discriminative abilities to accurately detect 
exaggerated response style of malingering (Preston & Colman, 2000).  This could also be a 
unique finding of this study.  Additional replication studies will help to validate the 
discriminative ability of the expanded Likert scale to detect malingered ADHD. 
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Catch Index.  An unexpected finding of this study was not just the malingering group’s 
responses on ADHD and symptom validity items, but also its high proportion of failures on the 
catch items.  Over a third (33.9%) of students instructed to malinger ADHD failed at least one 
catch item, and over one quarter of the group failed all three items.  These items were initially 
embedded to validate that an individual was paying attention to the study (i.e., reading the 
items), and they were not designed to be included as a part of a specific MARS index.  Yet, it 
appears as if a portion of malingerers believed these catch items to be genuine ADHD items that 
they should carelessly miss because they were “faking” the symptoms of ADHD (i.e., 
inattention).  But in actuality, no one in the ADHD group failed these items.  So the catch items 
“caught” malingerers trying to fake, while those with ADHD attended to them.  This unexpected 
finding could be of use in ADHD rating scales as a supplemental indicator of malingering.  
Although these preliminary findings need to be validated, this offers some potential use for catch 
items as embedded indicators of malingered ADHD. 
In conclusion, the results indicate that malingerers easily over-endorse ADHD symptom, 
impairment, and symptom validity items.  To detect cases of ADHD from controls, the use of the 
ADHD symptom indexes demonstrated higher classification accuracy in comparison to the 
remaining indexes.  As predicted, the SV-index demonstrated excellent classification accuracy to 
detect malingered ADHD.  The findings indicate the SV-index performs better at detecting 
malingered ADHD than any available validity measure.  The study findings suggest the utility of 
symptom over-report and “catch” items as additional validity indicators.  Impairment may 
slightly help differentiate ADHD from Control students, as well as malingerers from true 
ADHD.   Overall, the findings support the use of symptom, impairment, and symptom validity 
indexes to effectively detect ADHD (true positives) and malingering (true negatives). 
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Limitations 
 This is an analogue study that inherently has limitations.  The main limitation is the use 
of a simulation design.  In comparison to archival studies, a simulation study has improved 
internal validity with experimental control of the malingering group assignment.  Unfortunately, 
this is a contrived situation that reduces a study’s external validity.  A simulation study cannot 
adequately recreate the real life incentives and motivations for people to malinger a diagnosis 
(Rogers & Gillard, 2011).  For example, there are actual incentives for some individuals to 
effectively malinger ADHD in order to receive test accommodations on a high stakes exam (e.g., 
Law School Admissions Test).  The relative strengths and weaknesses of simulation designs 
must be considered in forming inferences from the findings. 
This simulation study is potentially limited by the simulation coaching instructions.  This 
study utilized a broad prompt for the malingering group to complete the MARS “faking the 
symptoms and diagnosis of ADHD,” and those who “deceive the clinician by faking ADHD” on 
the self-report measure were eligible for the incentive.  This was followed by 5-minutes of study 
with ADHD symptom information.  Recent research published after the inception of this study 
suggests that a simulation group is able to produce more “believable” ADHD symptom reports 
when coached on both symptoms and general ADHD assessment information (Fuermaier et al., 
2016).  As clinicians should expect actual malingerers to be well-prepared for the evaluation 
(Rogers & Gillard, 2011), future replication of this pilot study would benefit from additional 
coaching instructions to improve external validity of the findings. 
This study is also limited by the use of self-reported diagnoses of ADHD to comprise the 
ADHD group.  Although efforts were made to recruit participants with a verifiable diagnosis of 
ADHD, ultimately recruitment needed to expand to include those with a self-reported ADHD 
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diagnosis.  A phone screening was implemented to screen out false positive cases,, nevertheless, 
it is possible that a portion of the ADHD sample included individual’s that would not meet 
stringent criteria for the diagnosis.  As a result, the ADHD group may not be reflective of adult 
ADHD in the general population.  Therefore, these findings may not generalize to all persons 
with ADHD.  Additional research is needed to replicate these findings on a more precisely 
defined ADHD group, perhaps by expanding the study to additional clinics or junior and 
community college samples. 
Another limitation that affects the external validity of the findings involves the sample 
selection.  This was a convenient sample comprised of students and from a private university in 
the Northeast.  The Control group had a disproportionate number of students with English as a 
second language.  Further, the study did not collect information on intelligence, socioeconomic 
status, or pre-existing knowledge of ADHD.  These factors limit the generalizability of findings.  
Additional research with larger and more diverse samples is needed to replicate and extend the 
current work on this pilot measure. 
Additional Directions for Analyses and Research 
 This is an exploratory study of a newly constructed ADHD rating scale (MARS).  The 
findings and limitations offer avenues for further research on ADHD and Malingering 
classification.  If nothing else, further research is needed to replicate the results from the MARS 
and examine its applicability in clinical settings. 
This study provides introductory support for the face validity and discriminative validity 
of this multidimensional self-report measure.  However, these preliminary findings would benefit 
from replication that could substantiate, clarify, and better explain the findings.  Additionally, as 
this is a test construction project, this measure is in need of ongoing reliability and validity 
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testing.  For example, regression analyses should be conducted to examine the extent to which 
the index scores (and catch items) individually and collectively predict the presence of ADHD, 
as well as the detection of malingering.  Furthermore, factor analysis is needed to determine the 
actual structure of the multidimensional scale, and whether there is support for the five indexes 
of the measure (i.e., inattention, hyperactivity, ADHD total symptom, functional impairment, and 
symptom validity).  Research is also needed to conduct additional validity (e.g., convergent 
validity) and reliability (e.g., test-retest reliability) analyses necessary to determine the 
psychometric adequacy of the MARS.  Overall, the promising findings of this study indicate that 
additional data collection and analyses are warranted to continue to build confidence and support 
for the five indexes included in the MARS.   
The current study only performed an item reduction analysis on the symptom validity 
items.  Although reliability analyses suggested all items of the FI-index could be retained, there 
was no additional attempt in this study to find an optimum set of impairment items to comprise 
that scale.  It is best practices for ADHD evaluations to assess impairment (e.g., American 
Academy of Pediatrics, 2011), and a FI-index was constructed and included.  As many of these 
items were created for this pilot study, it is possible that the FI-index in this present study used 
extraneous items that depreciated the index’s diagnostic capabilities.  More research would need 
to be done to field test impairment items and determine the best set of items for assessing 
impairment in ADHD adults.  Future research needs to examine the efficacy of a diagnostic 
rating scale for ADHD that combines symptom and impairment measurement 
The seven-item SV-index demonstrated excellent sensitivity and specificity in this 
simulation study design.  It is unknown whether these items will remain effective at detecting 
malingering across various clinical samples.  As one should expect malingerers to be well-
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prepared for the evaluation (Rogers & Gillard, 2011), future extensions of this study would 
benefit from coaching the simulated malingering group on the ADHD diagnosis and evaluation 
process (e.g., Fuermaier et al., 2015).  The additional coaching may better prepare the non-
ADHD group to simulate malingering and improve external validity of the findings.  
Additionally, the MARS would benefit from cross-validation in a clinical sample with archival 
data.  Simulation studies have strong internal validity, while archival studies have increased 
external validity. The strengths of both research methodologies helps to provide the best support 
for creating a validity test to detect true cases of malingering (Rogers & Gilbert, 2011). 
Although the current study resulted in an SV-index of seven items, it certainly is 
plausible that other types of items could add to the classification accuracy and improve the scale.  
For example, the Malingering group over-reported on functional impairment items in comparison 
to those with ADHD.  This suggests the possibility that specific exaggerated functional 
impairment items could be added to the SV-index, or could form a separate symptom validity 
scale.  With this in mind, it is recommended that additional functional impairment items be 
created and pilot tested to determine their contribution as potential malingering indicators.  
Surprisingly, the catch items also emerged as an idea worth considering in an ADHD 
self-report measure.  In this study, the catch items demonstrated some ability to discriminate true 
from malingered ADHD.  Yet, it is unknown whether the catch items would yield similar 
diagnostic results with different simulation group instructions, different samples, and a much 
shorter rating scale (97 items were eventually eliminated from the MARS). Future research will 
help to determine whether some form of catch items can assist in the detection of ADHD 
malingering.   
	  57 
Additional analyses should explore the combined use of the MARS SV-index, Symptom 
Over-report cutpoints, and catch items to detect malingered ADHD.  Similar to the Exaggeration 
Index (Harrison & Armstrong, 2016), a weighted validity index could provide an additive ability 
to detect malingered ADHD.  Alternatively, future analyses should examine whether other 
formulations of the MARS items could detect this population.  For example, discriminant 
function analyses can be used to identify response patterns that are inconsistent with the clinical 
population (e.g., Rogers & Gillard, 2011).  These validity indexes are effective methods to detect 
other feigned populations (e.g., feigned psychopathology) and may be an effective strategy to 
identify malingered ADHD. 
In clinical settings, the identification of suspected malingering requires the use of 
multiple validity indicators (Larrabee, 2012; Rogers & Gillard, 2011).  Future research should 
investigate the MARS validity indicators along with other available SVTs (e.g., CAT-A) and 
PVTs (e.g., WMT).  This will help to establish convergent validity of the MARS validity 
indexes.  Additionally, this will reveal the combined contribution of these indicators towards 
detecting feigned ADHD.  Specifically, one can chain the likelihood ratios of multiple validity 
failures to determine the posttest odds of malingering (see Larrabee, 2012).  Ultimately, 
increased odds of malingering detection improve clinician confidence in accurate diagnostic 
determinations. 
Conclusion 
 This study provides preliminary evidence in support of a multidimensional ADHD self-
report measure that utilizes a symptom validity index to detect noncredible responding.  The 
results contribute to the literature that college students instructed to malinger ADHD can easily 
fake the symptom and impairment profile associated with ADHD.  The findings support the use 
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of an embedded symptom validity index to detect suspected cases of malingering, while other 
indexes identify true cases of ADHD.  This measure appears to be reliable, able to elicit 
symptom and impairment reports from ADHD college students, and able to detect malingered 
ADHD with high sensitivity and specificity.    
Additionally, the use of the expanded Likert scale appears to help detect symptom over-
report of simulated malingerers.  These preliminary findings suggest that the MARS warrants 
additional exploration to examine its psychometric characteristics and diagnostic properties.  If 
future research supports the study’s promising findings, this type of multidimensional measure 
could prove to be a valuable tool to help clinicians correctly and confidently identify both 
ADHD and malingering in adult diagnostic evaluations.
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Table 1 
 
Demographic Characteristics of the Sample 
 
Characteristic 
ADHD 
(n=39) 
Malingering 
(n=56) 
Control 
(n=62) 
 n % n % n % 
Ethnicitya       
Caucasian/White 31 79.5 36 64.3 28 45.2 
African American/Black 0 0.0 5 8.9 9 14.5 
Hispanic 4 10.3 4 7.1 7 11.3 
Asian 4 10.3 11 19.6 17 27.4 
Native American 0 0.0 0 0.0 1 1.6 
Year in Schoolb       
Freshman 11 28.2 42 75.0 39 62.9 
Sophomore 7 17.9 8 14.3 15 24.2 
Junior 7 17.9 2 3.6 4 6.5 
Senior 5 12.8 4 7.1 4 6.5 
Graduate 6 15.4 0 0.0 0 0.0 
Other 3 7.7 0 0.0 0 0.0 
First Languagec       
English 36 92.3 55 98.2 50 80.6 
Other 3 7.7 1 1.8 12 19.4 
School Problemsb       
No 17 43.6 47 83.9 55 88.7 
Yes  22 56.4 8 14.3 7 11.3 
Medicationb       
No 9 23.1 52 92.9 57 91.9 
Yes 30 76.9 4 7.1 5 8.1 
Regular Stimulant Useb       
No 17 43.6 54 96.4 60 96.8 
Yes 22 56.4 2 3.6 2 3.2 
       
ADHD Symptom Presentation ≥4 c       
Inattentive Presentation  11 28.2 2 3.6 9 14.5 
Hyperactive-Impulsive Presentation 2 5.1 1 1.8 2 3.2 
Combined Presentation 19 48.7 53 94.6 3 4.8 
       
ADHD Symptom Presentation ≥6 d       
Inattentive Presentation  9 23.1 9 16.1 1 1.6 
Hyperactive-Impulsive Presentation 0 0.0 2 3.6 0 0.0 
Combined Presentation 6 15.4 40 71.4 0 0.0 
Note. Significant between group differences (p < .006) on variables have the following notations: 
a) no differences between groups, b) ADHD different from Controls/Malingering, c) Controls 
different from ADHD/Malingering, and d) differences between all groups  
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Table 2 
 
Means and Standard Deviations of 104 Symptom Validity Items 
 
 
ADHD 
(n=39) 
Malingering 
(n=56) 
Control 
(n=62) 
Symptom Validity Item  M SD M SD M SD 
SV1.  1.90 2.13 4.34 2.35 .76 1.34 
SV2.  3.33 2.75 6.35 1.64 1.98 2.00 
SV3.  4.23 2.24 6.24 1.71 2.44 1.90 
SV4.  3.13 2.34 5.66 1.89 2.23 2.26 
SV5.  1.49 2.21 5.13 2.05 .48 1.23 
SV6.  4.67 2.37 6.61 1.56 3.24 2.27 
SV7.  1.77 2.39 4.80 2.68 .82 1.73 
SV8.  2.87 2.45 5.78 1.90 1.89 1.90 
SV9.  3.31 2.15 5.21 2.34 2.56 2.01 
SV10.  .23 0.74 3.02 2.66 .11 0.45 
SV11.  1.79 1.81 4.02 2.52 1.08 1.64 
SV12.  4.05 2.36 6.36 1.59 2.31 1.62 
SV13.  3.64 2.97 5.64 2.08 1.68 1.85 
SV14.  3.10 2.39 4.98 2.10 2.16 1.80 
SV15.  3.36 2.66 5.75 1.75 1.34 1.51 
SV16.  5.21 1.85 6.29 1.60 3.32 1.76 
SV17.  2.95 2.24 5.86 1.60 1.16 1.36 
SV18  3.18 2.65 6.18 1.48 1.66 1.63 
SV19.  2.05 2.42 5.05 2.04 .85 1.52 
SV20.  2.21 2.17 5.57 2.04 1.69 1.70 
SV21.  2.74 2.22 5.25 1.96 .84 1.52 
SV22.  .13 0.41 2.69 2.52 .05 0.22 
SV23.  2.00 2.66 3.95 2.59 .74 1.24 
SV24.  4.41 2.36 6.16 1.55 1.98 2.18 
SV25.  1.00 1.25 4.52 2.22 .58 1.14 
SV26.  3.74 2.53 5.38 2.09 2.50 2.13 
SV27.  3.51 2.28 5.56 2.21 1.97 2.24 
SV28.  1.90 1.70 5.70 1.97 .84 1.45 
SV29.  1.77 2.62 5.34 2.10 1.11 1.57 
SV30.  4.44 2.21 5.93 1.79 3.61 2.09 
SV31.  3.67 2.45 6.02 1.64 1.97 2.01 
SV32.  1.46 2.11 5.00 2.36 1.19 1.75 
SV33.  2.08 2.42 5.62 1.92 .81 1.37 
SV34.  2.51 2.68 5.54 2.09 1.50 1.86 
SV35  2.92 2.06 6.13 1.66 1.79 2.14 
SV36.  3.03 1.90 4.16 2.71 1.79 1.70 
SV37.  2.67 2.24 5.79 1.78 0.79 1.28 
SV38.  2.15 2.17 4.63 2.28 2.23 2.12 
SV39.  4.21 2.07 5.88 1.73 2.89 1.89 
SV40.  2.41 2.20 5.30 2.37 1.24 1.55 
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Table 2 continued       
 ADHD Malingering Control 
Symptom Validity Item M SD M SD M SD 
SV41.  2.13 2.17 5.36 2.10 0.85 1.39 
SV42.  2.10 2.22 5.91 1.80 1.98 1.94 
SV43.  2.31 2.86 5.25 2.07 2.71 2.58 
SV44.  3.00 2.40 6.54 1.39 2.29 1.99 
SV45.  2.36 2.64 4.89 2.35 1.05 1.81 
SV46.  2.08 2.30 5.84 1.71 1.76 2.02 
SV47.  4.67 2.40 6.49 1.76 3.30 2.12 
SV48.  2.23 2.19 5.50 1.84 1.44 1.92 
SV49.  2.31 2.28 4.38 2.45 1.32 1.90 
SV50.  2.41 2.29 5.95 1.80 1.66 1.90 
SV51.  2.21 2.40 5.47 2.18 1.49 1.70 
SV52.  2.18 2.06 5.84 1.82 0.89 1.31 
SV53.  2.08 2.07 5.22 2.35 1.23 1.44 
SV54.  1.69 2.07 5.05 1.67 1.03 1.57 
SV55.  2.56 2.44 5.84 1.79 1.98 2.06 
SV56.  1.38 2.03 5.02 2.07 0.61 1.19 
SV57.  2.54 2.35 5.91 2.06 1.53 1.66 
SV58.  1.44 2.19 4.68 2.57 1.18 1.70 
SV59.  2.62 2.32 6.09 1.76 1.44 1.75 
SV60.  1.62 2.17 5.43 1.97 1.10 1.49 
SV61.  1.85 2.31 4.71 2.40 0.89 1.48 
SV62.  2.41 2.80 5.24 2.45 1.24 1.90 
SV63.  3.15 2.28 5.73 1.75 2.55 2.05 
SV64.  2.45 2.18 5.25 2.25 1.02 1.49 
SV65.  1.97 2.24 5.25 2.06 0.81 1.32 
SV66.  2.54 2.00 5.73 1.71 1.42 1.74 
SV67  1.38 1.66 5.09 2.13 0.68 1.07 
SV68.  2.28 1.93 5.76 1.85 1.37 1.69 
SV69.  2.38 2.51 5.38 2.18 1.55 2.02 
SV70.  2.51 2.59 5.47 1.77 1.87 2.16 
SV71.  1.92 2.02 5.09 2.17 1.05 1.32 
SV72.  2.10 2.11 6.07 1.73 1.55 1.81 
SV73.  2.77 2.33 5.82 1.74 1.31 1.69 
SV74.  3.26 2.53 5.63 1.65 1.35 1.65 
SV75.  3.72 2.46 6.25 1.73 2.26 2.03 
SV76.  0.82 1.41 4.00 2.70 0.63 1.12 
SV77.  3.95 2.91 6.21 2.06 1.89 2.36 
SV78.  3.23 2.35 5.36 2.18 1.61 2.04 
SV79.  3.41 2.45 5.52 2.09 1.81 1.99 
SV80.  3.23 2.36 5.84 1.79 2.32 2.30 
SV81.  3.15 2.42 5.66 1.71 1.69 2.15 
SV82  1.44 1.89 4.39 2.48 .77 1.41 
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Table 2 continued       
 ADHD Malingering Control 
Symptom Validity Item M SD M SD M SD 
SV83.  3.62 1.96 5.75 1.92 3.02 1.96 
SV84.  3.77 2.68 6.23 1.58 2.24 2.23 
SV85.  2.59 2.46 5.79 1.95 1.69 2.08 
SV86.  3.00 2.72 6.63 1.30 2.21 1.98 
SV87.  3.46 1.83 6.07 2.13 3.81 2.00 
SV88.  4.41 2.09 6.15 1.88 2.82 2.00 
SV89.  3.41 2.85 5.09 1.98 2.61 2.29 
SV90.  1.56 1.71 4.91 2.15 .68 1.07 
SV91.  2.00 2.25 5.41 2.33 1.97 2.27 
SV92.  3.97 2.07 5.41 2.15 2.10 1.54 
SV93.  3.77 2.19 6.48 1.66 3.05 2.16 
SV94.  2.56 2.06 5.73 1.76 1.40 1.69 
SV95.  1.92 2.16 4.52 2.41 0.95 1.15 
SV96.  2.15 2.36 4.93 1.75 1.26 1.62 
SV97.  3.51 2.35 5.16 2.15 2.29 1.99 
SV98.  2.21 2.17 4.57 2.30 2.11 1.89 
SV99.  4.38 2.30 6.46 1.56 3.11 1.85 
SV100.  3.36 2.61 5.64 2.14 2.89 2.09 
SV101.  4.67 2.32 6.52 1.39 2.95 1.92 
SV102.  2.62 2.29 5.20 1.91 1.24 1.58 
SV103. 1.90 1.77 4.11 2.53 1.52 1.82 
SV104.  2.62 2.15 5.27 2.18 1.63 1.87 
Note.  Malingering > ADHD > Control for all items.  Item names removed to maintain test 
security. 
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Table 3 
 
Means and Standard Deviations of 11 Symptom Validity Items ≤2 in ADHD and Control Groups 
and ≥5 in Malingering Group 
 ADHD Malingering Control 
 
Symptom Validity Item M SD M SD M SD 
SV5.  1.49 2.21 5.13 2.05 .48 1.23 
SV28.  1.90 1.70 5.70 1.97 .84 1.45 
SV29.  1.77 2.62 5.34 2.10 1.11 1.57 
SV32.  1.46 2.11 5.00 2.36 1.19 1.75 
SV54.  1.69 2.07 5.05 1.67 1.03 1.57 
SV56.  1.38 2.03 5.02 2.07 0.61 1.19 
SV60.  1.62 2.17 5.43 1.97 1.10 1.49 
SV65.  1.97 2.24 5.25 2.06 0.81 1.32 
SV67.  1.38 1.66 5.09 2.13 0.68 1.07 
SV71.  1.92 2.02 5.09 2.17 1.05 1.32 
SV91.  2.00 2.25 5.41 2.33 1.97 2.27 
Note.  Malingering > ADHD > Control for all items.  Item names removed to maintain test 
security. 
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Table 4 
 
Final 7-Item Symptom Validity Index  
 ADHD Malingering  
 
Symptom Validity Item M SD M SD M Difference 
SV5.  1.49 2.21 5.13 2.05 3.64 
SV28.  1.90 1.70 5.70 1.97 3.80 	  
SV29.  1.77 2.62 5.34 2.10 3.57 	  
SV32.  1.46 2.11 5.00 2.36 3.54 
SV56.  1.38 2.03 5.02 2.07 3.64 
SV60.  1.62 2.17 5.43 1.97 3.81 
SV67.  1.38 1.66 5.09 2.13 3.71 
Note.  Malingering > ADHD for all items.  Item names removed to maintain test security. 
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Table 5 
 
Means and Standard Deviations of ADHD Inattention Symptom Items 
 
 
 
ADHD 
(n=39) 
 
Malingering 
(n=56) 
 
Control 
(n=62) 
Inattention Symptom Item M SD M SD M SD 
Fail to give close attention to 
details or make careless 
mistakes in my work 
4.77 2.40 6.48 1.64 2.40 1.44 
Difficulty sustaining attention in 
tasks or play activities 4.28 1.86 6.41 1.40 2.00 1.64 
Do not listen when spoken to 
directly (mind seems 
elsewhere) 
4.21 2.31 6.21 1.68 2.34 1.76 
Do not follow through with 
instructions and fail to finish 
schoolwork, chores, or work 
duties 
4.28 2.38 6.57 1.55 1.87 1.73 
Difficulty organizing tasks and 
activities 4.38 1.98 6.38 1.75 2.11 1.96 
Avoid, dislike, or reluctant to 
engage in tasks that require 
sustained mental effort 
4.28 2.25 6.27 1.70 2.26 1.77 
Lose things necessary for tasks or 
activities 3.90 2.49 6.20 1.39 2.21 1.82 
Easily distracted by extraneous 
stimuli or irrelevant thoughts 5.69 1.87 6.98 1.12 3.31 2.01 
Forgetful in daily activities 4.13 2.35 6.36 1.72 2.26 1.77 
Note.  Malingering > ADHD > Control for all items. 
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Table 6 
 
Means and Standard Deviations of ADHD Hyperactivity-Impulsivity Symptom Items 
 
 
ADHD 
(n=39) 
Malingering 
(n=56) 
Control 
(n=62) 
Hyperactivity Symptom Item M SD M SD M SD 
Fidget in seat by squirming, 
tapping my hands and/or 
my feet 
5.08 2.48 6.86 1.47 2.53 2.53 
Leave my seat when remaining 
seated is expected 2.13 2.02 5.79 1.83 0.90 1.18 
Run about or climb in 
situations where it is 
inappropriate 
1.97 2.22 5.52 1.91 1.06 1.57 
Unable to play or engage in 
leisure activities quietly 2.74 2.02 6.14 1.52 1.65 1.63 
Constantly on the go/driven by 
motor 4.41 2.11 6.20 2.00 2.63 1.99 
Talk excessively 4.31 2.38 6.39 1.55 2.45 2.05 
Blurt out an answer before a 
question has been 
completed 
2.95 2.36 6.07 1.78 2.19 1.71 
Have difficulty waiting for my 
turn 3.49 2.35 6.59 1.22 1.90 1.74 
Interrupt or intrude on others 
(butt into conversations or 
activities without 
permission) 
3.08 2.31 6.11 1.66 1.92 1.76 
Note.  Malingering > ADHD > Control for all items. 
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Table 7 
 
Means and Standard Deviations of Functional Impairment Items 
 
 
ADHD 
(n=38) 
Malingering 
(n=56) 
Control 
(n=62) 
Functional Impairment Item M SD M SD M SD 
In home life with immediate 
family 3.32 2.57 4.80 2.28 1.45 1.72 
In getting household chores 
completed 4.18 2.72 6.09 1.90 1.94 1.77 
In managing daily activities 4.03 2.15 6.20 1.91 1.74 1.73 
In my social interactions with 
strangers 3.00 2.18 5.52 2.53 2.00 2.14 
In my work/job 3.05 2.49 5.91 2.50 1.56 1.74 
In budgeting my money, bills, 
and/or debt 3.97 2.56 6.41 1.59 3.03 2.35 
In operating a motor vehicle 1.47 2.05 4.43 2.78 .69 1.28 
In my relationships with friends 2.74 2.46 4.95 2.42 1.90 2.04 
In my marital, or partner, or 
dating relationships 2.32 2.49 5.20 2.36 1.79 2.28 
In my educational classes (e.g., 
attendance) 3.39 2.70 6.63 1.90 2.92 2.22 
In my performance on 
educational tests/assignments 3.61 2.73 6.70 1.89 2.97 2.36 
In controlling my behavior at 
work, home, or school 2.95 2.45 5.91 2.20 1.19 1.82 
In my decision making at work, 
home, or school 3.82 2.30 6.20 1.77 1.94 2.01 
In maintaining hygiene 
(dressing, showing) 2.18 2.39 4.21 2.73 .89 1.47 
In self-care (e.g., sleeping, 
eating) 3.58 2.54 5.16 2.22 2.37 2.14 
In social activities 3.13 2.28 5.13 2.36 2.26 2.25 
In community-based activities 
(e.g., church, clubs, 
organizations) 
1.87 2.12 5.48 2.20 1.32 2.05 
In maintaining my health (e.g., 
nutrition, exercise) 3.42 2.48 4.88 2.38 2.60 2.36 
In time management 4.71 2.37 7.09 1.33 3.34 2.52 
In meeting deadlines 4.13 2.46 6.57 2.15 2.34 2.53 
With controlling my anger 2.45 2.35 5.14 2.45 1.37 1.65 
With my memory for daily 
activities 4.47 2.66 6.09 2.18 2.00 2.20 
Note.  Malingering > ADHD > Control for all items. 
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Note.  Malingering > ADHD > Control for all indexes. 
 
 
 
 
 
 
 
Table 8 
 
Means and Standard Deviations of the Five Indexes 
 
 ADHD Malingering Control  
Index M SD M SD M SD ω2 
ADHD Inattention 
Index  39.92 14.46 58.12 9.09 20.76 11.38 .66 
ADHD Hyperactivity-
Impulsivity Index 30.15 14.78 55.88 10.41 17.24 8.96 .70 
ADHD Total Index 70.08 26.06 114.00 17.69 38.00 17.59 .73 
Functional Impairment 
Index  71.79 37.46 124.68 36.39 43.20 28.92 .52 
Symptom Validity 
Index 10.74 10.12 36.70 10.93 5.68 5.32 .71 
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Table 9 
 
Coordinates of the ROC Curve for the ADHD Inattention Index 
Classifying ADHD between the ADHD and Control groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
1.0 1.00 0.98 
3.0 1.00 0.97 
4.5 1.00 0.95 
5.5 1.00 0.94 
6.5 1.00 0.89 
7.5 1.00 0.87 
8.5 0.97 0.87 
9.5 0.97 0.86 
10.5 0.95 0.84 
11.5 0.95 0.77 
12.5 0.95 0.76 
13.5 0.95 0.74 
15.0 0.90 0.69 
16.5 0.90 0.66 
17.5 0.90 0.63 
18.5 0.90 0.53 
20.0 0.90 0.47 
21.5 0.87 0.42 
22.5 0.87 0.31 
23.5 0.85 0.31 
25.0 0.85 0.29 
26.5 0.82 0.26 
27.5 0.82 0.24 
28.5 0.74 0.21 
29.5 0.74 0.19 
30.5 0.72 0.18 
32.5 0.72 0.15 
34.5 0.72 0.13 
35.5 0.69 0.11 
36.5 0.62 0.11 
37.5 0.59 0.11 
38.5 0.56 0.10 
39.5 0.54 0.08 
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Table 9 continued 
Cutpoint ≥ Sensitivity 1 - Specificity 
41.0 0.51 0.08 
43.0 0.49 0.07 
45.0 0.49 0.05 
46.5 0.41 0.05 
47.5 0.39 0.02 
48.5 0.36 0.00 
49.5 0.33 0.00 
50.5 0.26 0.00 
51.5 0.23 0.00 
52.5 0.18 0.00 
53.5 0.15 0.00 
54.5 0.13 0.00 
57.5 0.08 0.00 
60.5 0.05 0.00 
62.0 0.03 0.00 
64.0 0.00 0.00 
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Table 10 
 
Coordinates of the ROC Curve for the ADHD Hyperactivity 
Index Classifying ADHD between the ADHD and Control groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
1.0 1.00 1.00 
3.0 1.00 0.95 
4.5 1.00 0.92 
5.5 1.00 0.89 
6.5 0.95 0.87 
7.5 0.92 0.81 
9.0 0.92 0.79 
10.5 0.87 0.76 
11.5 0.87 0.73 
12.5 0.87 0.66 
13.5 0.82 0.63 
14.5 0.82 0.57 
15.5 0.82 0.53 
16.5 0.82 0.50 
17.5 0.80 0.48 
18.5 0.74 0.48 
19.5 0.74 0.44 
20.5 0.69 0.42 
21.5 0.67 0.40 
22.5 0.67 0.29 
24.0 0.64 0.24 
25.5 0.62 0.21 
26.5 0.62 0.15 
27.5 0.62 0.08 
28.5 0.56 0.08 
29.5 0.54 0.07 
30.5 0.49 0.07 
31.5 0.41 0.07 
32.5 0.41 0.05 
33.5 0.39 0.05 
34.5 0.36 0.02 
35.5 0.33 0.02 
37.0 0.31 0.02 
39.0 0.28 0.02 
41.0 0.26 0.00 
42.5 0.23 0.00 
44.5 0.18 0.00 
46.5 0.15 0.00 
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Table 10 continued  
Cutpoint ≥ Sensitivity 1 - Specificity 
48.0 0.13 0.00 
51.5 0.10 0.00 
55.5 0.05 0.00 
58.5 0.03 0.00 
61.0 0.00 0.00 
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Table 11 
 
Coordinates of the ROC Curve for the ADHD Total Index 
Classifying ADHD from ADHD and Control groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
5.00 1.00 1.00 
6.50 1.00 0.98 
7.50 1.00 0.95 
10.00 1.00 0.94 
12.50 1.00 0.92 
14.50 1.00 0.90 
16.50 1.00 0.86 
17.50 1.00 0.84 
19.00 1.00 0.82 
20.50 0.97 0.82 
21.50 0.92 0.82 
22.50 0.92 0.81 
23.50 0.92 0.79 
24.50 0.92 0.74 
26.00 0.92 0.73 
27.50 0.90 0.69 
28.50 0.90 0.66 
31.00 0.90 0.63 
33.50 0.90 0.61 
34.50 0.87 0.57 
35.50 0.87 0.55 
36.50 0.87 0.52 
37.50 0.87 0.50 
39.50 0.87 0.47 
41.50 0.85 0.44 
43.00 0.85 0.40 
45.00 0.85 0.37 
46.50 0.82 0.34 
47.50 0.82 0.32 
48.50 0.82 0.31 
49.50 0.82 0.29 
50.50 0.82 0.27 
51.50 0.80 0.26 
52.50 0.80 0.24 
53.50 0.77 0.23 
54.50 0.72 0.19 
55.50 0.69 0.18 
56.50 0.69 0.15 
57.50 0.67 0.13 
58.50 0.67 0.11 
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Table 11 continued 
Cutpoint ≥ Sensitivity 1 - Specificity 
60.00 0.64 0.11 
62.00 0.64 0.10 
63.50 0.64 0.08 
64.50 0.59 0.07 
65.50 0.56 0.07 
66.50 0.54 0.07 
68.50 0.54 0.05 
70.50 0.54 0.03 
71.50 0.54 0.02 
72.50 0.49 0.02 
75.00 0.49 0.00 
77.50 0.44 0.00 
78.50 0.36 0.00 
81.00 0.33 0.00 
83.50 0.31 0.00 
85.00 0.28 0.00 
87.00 0.26 0.00 
89.50 0.23 0.00 
92.00 0.21 0.00 
95.50 0.15 0.00 
99.00 0.13 0.00 
104.50 0.10 0.00 
109.50 0.08 0.00 
112.50 0.05 0.00 
117.50 0.03 0.00 
121.00 0.00 0.00 
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Table 12 
 
Coordinates of the Curve for the Functional Impairment Index 
Classifying ADHD between ADHD and Control groups 
Cutpoint ≥  Sensitivity 1 - Specificity 
1.00 0.97 1.00 
6.00 0.97 0.97 
10.50 0.97 0.92 
11.50 0.97 0.90 
13.50 0.97 0.89 
15.50 0.95 0.87 
16.50 0.95 0.81 
17.50 0.95 0.77 
18.50 0.92 0.74 
20.50 0.92 0.73 
22.50 0.92 0.69 
24.50 0.90 0.68 
27.50 0.90 0.66 
29.50 0.87 0.66 
30.50 0.84 0.65 
31.50 0.84 0.61 
32.50 0.84 0.58 
33.50 0.82 0.58 
34.50 0.82 0.57 
35.50 0.82 0.53 
37.00 0.82 0.48 
39.00 0.79 0.45 
40.50 0.79 0.44 
41.50 0.76 0.42 
43.00 0.76 0.40 
45.00 0.76 0.39 
46.50 0.76 0.36 
48.00 0.76 0.34 
49.50 0.76 0.32 
50.50 0.74 0.32 
51.50 0.71 0.31 
52.50 0.68 0.29 
54.00 0.68 0.27 
55.50 0.66 0.27 
57.50 0.66 0.24 
60.00 0.63 0.23 
62.00 0.61 0.21 
63.50 0.55 0.21 
64.50 0.53 0.21 
65.50 0.50 0.21 
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Table 12 continued   
Cutpoint ≥  Sensitivity 1 - Specificity 
67.50 0.47 0.21 
69.50 0.45 0.19 
70.50 0.42 0.18 
71.50 0.40 0.18 
75.00 0.40 0.16 
79.00 0.37 0.13 
81.00 0.34 0.13 
85.00 0.32 0.13 
91.00 0.29 0.13 
95.50 0.24 0.11 
98.50 0.21 0.08 
102.00 0.21 0.07 
104.43 0.18 0.05 
104.93 0.18 0.02 
114.00 0.18 0.00 
124.50 0.16 0.00 
126.50 0.13 0.00 
129.00 0.11 0.00 
134.50 0.08 0.00 
138.50 0.05 0.00 
140.00 0.03 0.00 
142.00 0.00 0.00 
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Table 13 
 
Coordinates of the Curve for the Symptom Validity Index 
Classifying ADHD between ADHD and Control groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
0.50 0.95 0.81 
1.50 0.90 0.76 
2.50 0.80 0.61 
3.50 0.64 0.57 
4.50 0.62 0.48 
5.50 0.54 0.42 
6.50 0.49 0.37 
7.50 0.44 0.27 
8.50 0.41 0.24 
9.50 0.41 0.23 
10.50 0.39 0.21 
11.50 0.39 0.16 
12.50 0.31 0.15 
13.50 0.31 0.13 
14.50 0.28 0.11 
15.50 0.28 0.10 
16.50 0.28 0.07 
17.50 0.28 0.00 
19.50 0.23 0.00 
22.50 0.21 0.00 
25.50 0.13 0.00 
28.50 0.10 0.00 
30.50 0.05 0.00 
32.00 0.00 0.00 
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Table 14 
 
Coordinates of the Curve for the ADHD Inattention Index Classifying 
Malingering between the ADHD and Malingering Groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
7.00 1.00 1.00 
9.00 1.00 0.97 
12.00 1.00 0.95 
17.50 1.00 0.90 
22.00 1.00 0.87 
24.50 1.00 0.85 
27.00 1.00 0.82 
29.00 1.00 0.74 
32.50 1.00 0.72 
35.50 1.00 0.69 
36.50 1.00 0.62 
37.50 1.00 0.59 
38.50 1.00 0.56 
39.50 1.00 0.54 
40.43 0.98 0.51 
40.93 0.96 0.51 
41.50 0.95 0.51 
42.50 0.95 0.49 
43.50 0.91 0.49 
45.00 0.88 0.49 
46.50 0.88 0.41 
47.50 0.86 0.39 
48.50 0.82 0.36 
49.50 0.82 0.33 
50.50 0.79 0.26 
51.50 0.77 0.23 
52.50 0.73 0.18 
53.50 0.70 0.15 
54.50 0.66 0.13 
55.50 0.63 0.08 
56.50 0.57 0.08 
57.50 0.52 0.08 
58.50 0.50 0.08 
59.50 0.48 0.08 
60.50 0.45 0.05 
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Table 14 continued 
Cutpoint ≥ Sensitivity 1 - Specificity 
61.50 0.41 0.03 
62.50 0.36 0.03 
64.00 0.32 0.00 
65.50 0.25 0.00 
66.50 0.20 0.00 
67.50 0.16 0.00 
68.50 0.14 0.00 
69.50 0.11 0.00 
70.50 0.09 0.00 
71.50 0.07 0.00 
73.00 0.00 0.00 
61.50 0.41 0.03 
62.50 0.36 0.03 
64.00 0.32 0.00 
65.50 0.25 0.00 
66.50 0.20 0.00 
67.50 0.16 0.00 
68.50 0.14 0.00 
69.50 0.11 0.00 
70.50 0.09 0.00 
71.50 0.07 0.00 
73.00 0.00 0.00 
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Table 15 
 
Coordinates of the Curve for the ADHD Hyperactivity Index  
Classifying Malingering between the ADHD and Malingering Groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
5.00 1.00 1.00 
6.50 1.00 0.95 
8.50 1.00 0.92 
11.50 1.00 0.87 
15.00 1.00 0.82 
17.50 1.00 0.80 
19.00 1.00 0.74 
20.50 1.00 0.69 
22.00 1.00 0.67 
24.00 1.00 0.64 
26.50 1.00 0.62 
28.50 1.00 0.56 
29.50 1.00 0.54 
30.50 0.98 0.49 
32.00 0.98 0.41 
33.50 0.98 0.39 
34.50 0.98 0.36 
35.05 0.98 0.33 
35.55 0.96 0.33 
37.00 0.95 0.31 
38.50 0.93 0.28 
39.50 0.91 0.28 
41.00 0.91 0.26 
42.50 0.89 0.23 
43.50 0.89 0.18 
44.50 0.88 0.18 
45.50 0.86 0.18 
46.50 0.82 0.15 
47.50 0.79 0.13 
48.50 0.77 0.13 
49.50 0.75 0.10 
50.50 0.71 0.10 
51.50 0.61 0.10 
53.00 0.57 0.10 
55.50 0.50 0.05 
58.00 0.46 0.03 
59.50 0.45 0.03 
60.50 0.41 0.00 
61.50 0.38 0.00 
	  81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 15 continued 
Cutpoint ≥ Sensitivity 1 - Specificity 
62.50 0.32 0.00 
63.50 0.27 0.00 
64.50 0.25 0.00 
65.50 0.23 0.00 
66.50 0.18 0.00 
67.50 0.14 0.00 
68.50 0.11 0.00 
69.50 0.07 0.00 
71.00 0.05 0.00 
73.00 0.00 0.00 
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Table 16 
 
Coordinates of the curve for the ADHD Total Index Classifying 
Malingering between the ADHD and Malingering Groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
19.00 1.00 1.00 
20.50 1.00 0.97 
24.00 1.00 0.92 
30.50 1.00 0.90 
37.50 1.00 0.87 
43.50 1.00 0.85 
48.50 1.00 0.82 
52.00 1.00 0.80 
53.50 1.00 0.77 
54.50 1.00 0.72 
56.00 1.00 0.69 
58.00 1.00 0.67 
61.50 1.00 0.64 
64.50 1.00 0.59 
65.50 1.00 0.56 
68.43 1.00 0.54 
71.43 0.98 0.54 
74.00 0.98 0.49 
76.50 0.96 0.49 
77.50 0.96 0.44 
78.50 0.96 0.36 
81.00 0.96 0.33 
83.50 0.95 0.31 
85.00 0.95 0.28 
86.50 0.95 0.26 
87.50 0.93 0.26 
89.50 0.93 0.23 
92.00 0.93 0.21 
93.50 0.93 0.15 
94.50 0.88 0.15 
95.50 0.84 0.15 
96.05 0.82 0.15 
97.05 0.80 0.15 
99.00 0.79 0.13 
100.50 0.79 0.10 
101.50 0.77 0.10 
103.00 0.75 0.10 
104.50 0.71 0.10 
105.50 0.70 0.10 
106.50 0.66 0.10 
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Table 16 continued 
Cutpoint ≥ Sensitivity 1 - Specificity 
107.50 0.64 0.10 
108.50 0.59 0.10 
109.50 0.57 0.08 
110.50 0.55 0.05 
111.50 0.50 0.05 
112.50 0.48 0.05 
113.50 0.46 0.05 
114.50 0.45 0.05 
116.50 0.43 0.03 
119.00 0.39 0.03 
120.50 0.38 0.00 
121.50 0.36 0.00 
122.50 0.34 0.00 
124.50 0.30 0.00 
126.50 0.27 0.00 
127.50 0.25 0.00 
130.00 0.23 0.00 
133.00 0.18 0.00 
135.00 0.16 0.00 
136.50 0.13 0.00 
137.50 0.11 0.00 
138.50 0.09 0.00 
139.50 0.07 0.00 
142.00 0.05 0.00 
145.00 0.00 0.00 
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Table 17 
 
Coordinates of the curve for the Functional Impairment Index 
Classifying Malingering between the ADHD and Malingering Groups 
Cutpoint ≥  Sensitivity 1 - Specificity 
7.50 1.00 0.97 
16.50 1.00 0.95 
20.50 1.00 0.92 
26.00 1.00 0.90 
29.50 1.00 0.87 
31.50 1.00 0.84 
35.00 1.00 0.82 
37.50 0.98 0.82 
39.50 0.98 0.79 
45.50 0.96 0.76 
50.50 0.96 0.74 
51.50 0.96 0.71 
53.50 0.96 0.68 
55.50 0.96 0.66 
56.50 0.95 0.66 
58.00 0.93 0.66 
60.00 0.93 0.63 
62.00 0.93 0.61 
63.50 0.93 0.55 
64.50 0.93 0.53 
65.50 0.91 0.50 
67.50 0.91 0.47 
69.50 0.89 0.45 
70.50 0.89 0.42 
72.00 0.89 0.40 
74.00 0.88 0.40 
75.50 0.86 0.40 
77.00 0.82 0.40 
79.00 0.82 0.37 
80.50 0.82 0.34 
81.50 0.80 0.34 
85.00 0.80 0.32 
91.00 0.80 0.29 
95.00 0.80 0.24 
96.50 0.79 0.24 
100.50 0.77 0.21 
104.50 0.75 0.18 
106.50 0.73 0.18 
109.00 0.71 0.18 
112.00 0.70 0.18 
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Table 17 continued 
Cutpoint ≥  Sensitivity 1 - Specificity 
115.00 0.68 0.18 
117.50 0.66 0.18 
121.00 0.64 0.18 
123.50 0.63 0.16 
125.00 0.61 0.16 
126.50 0.59 0.13 
127.50 0.57 0.11 
129.00 0.55 0.11 
130.50 0.54 0.11 
132.00 0.50 0.08 
133.50 0.48 0.08 
134.50 0.46 0.08 
136.00 0.45 0.08 
137.50 0.41 0.08 
138.50 0.41 0.05 
140.00 0.39 0.03 
142.00 0.39 0.00 
144.50 0.36 0.00 
146.50 0.34 0.00 
149.00 0.30 0.00 
151.50 0.29 0.00 
152.50 0.27 0.00 
153.50 0.25 0.00 
154.50 0.23 0.00 
155.50 0.21 0.00 
158.00 0.16 0.00 
160.50 0.14 0.00 
162.50 0.13 0.00 
165.00 0.11 0.00 
167.50 0.07 0.00 
172.00 0.05 0.00 
175.50 0.04 0.00 
177.00 0.00 0.00 
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Table 18 
 
Coordinates of the curve for the Symptom Validity Index Classifying 
Malingering between the ADHD and Malingering Groups 
Cutpoint ≥ Sensitivity 1 - Specificity 
0.50 1.00 0.95 
1.50 1.00 0.90 
2.50 1.00 0.80 
3.50 1.00 0.64 
4.50 1.00 0.62 
5.50 1.00 0.54 
6.50 1.00 0.49 
7.50 0.98 0.44 
9.00 0.98 0.41 
10.50 0.98 0.39 
11.50 0.96 0.39 
13.00 0.95 0.31 
16.00 0.95 0.28 
18.50 0.95 0.23 
20.00 0.93 0.23 
21.50 0.93 0.21 
23.00 0.91 0.21 
24.50 0.89 0.13 
25.50 0.84 0.13 
26.50 0.82 0.13 
28.00 0.79 0.10 
29.50 0.73 0.10 
30.50 0.71 0.05 
31.50 0.71 0.00 
32.50 0.68 0.00 
33.50 0.66 0.00 
35.00 0.64 0.00 
36.50 0.61 0.00 
38.00 0.48 0.00 
39.50 0.43 0.00 
40.50 0.39 0.00 
41.50 0.36 0.00 
42.50 0.32 0.00 
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Table 18 continued 
Cutpoint ≥  Sensitivity 1 - Specificity 
43.50 0.30 0.00 
44.50 0.23 0.00 
45.50 0.20 0.00 
46.50 0.18 0.00 
47.50 0.13 0.00 
49.00 0.11 0.00 
50.50 0.07 0.00 
53.50 0.05 0.00 
57.00 0.00 0.00 
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Table 19 
 
Area under the Curve from Receiver Operating Characteristic Analyses for the Five Indexes Classifying ADHD 
between ADHD and Control Groups  
  
Confidence Interval 
 
Index 
 
AUC 
Standard 
Error  
 
p value 
 
Lower 
 
Upper 
ADHD Inattention Index  0.84 0.04 0.00 0.76 0.93 
ADHD Hyperactivity-Impulsivity 
Index 0.76 0.05 0.00 0.66 0.86 
ADHD Total Index 0.84 0.04 0.00 0.75 0.93 
Functional Impairment Index 0.73 0.05 0.00 0.63 0.83 
Symptom Validity Index 0.64 0.06 0.02 0.53 0.75 	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Table 20 
 
Area Under the Curve from Receiver Operating Characteristic Analyses for the Five Indexes Classifying Malingering 
between ADHD and Malingering Groups 
  
Confidence Interval 
 
Index 
 
AUC 
Standard 
Error  
 
p value 
 
Lower 
 
Upper 
ADHD Inattention Index  0.86 0.04 0.00 0.79 0.94 
ADHD Hyperactivity-Impulsivity 
Index 0.92 0.03 0.00 0.86 0.97 
ADHD Total Index 0.92 0.03 0.00 0.86 0.98 
Functional Impairment Index 0.84 0.04 0.00 0.76 0.92 
Symptom Validity Index 0.95 0.02 0.00 0.91 0.99 	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Table 21 
 
Optimal Sensitivity and Specificity Thresholds and Associated Psychometric Properties for the MARS Indexes Predicting ADHD 
between ADHD and Controls 
    
38.6% Base Rate (Current Study) 
 
5% Base Rate 
 
Index Cut Score 
Correct 
Classification 
 
Sensitivity 
 
Specificity 
 
PPP 
 
NPP 
 
PPP 
 
NPP 
ADHD Inattentive Index         
Optimal Sensitivity  20.0 67.3 89.7 53.2 54.7 89.2 9.2 99.0 
Optimal Specificity  38.5 77.2 56.4 90.3 78.6 76.7 23.4 97.5 
ADHD Hyperactivity-
Impulsivity Index  
       
Optimal Sensitivity  12.5 54.5 87.2 33.9 45.3 80.8 6.5 98.1 
Optimal Specificity  27.5 80.2 61.5 91.9 82.8 79.2 28.6 97.8 
ADHD Total Index         
Optimal Sensitivity  33.5 58.4 89.7 38.7 48.0 85.7 7.2 98.6 
Optimal Specificity  62.0 80.2 64.1 90.3 80.7 80.0 25.8 98.0 
Functional Impairment 
Index  
       
Optimal Sensitivity  27.5 55.0 89.5 33.9 45.3 84.0 6.7 98.4 
Optimal Specificity  95.5 64.0 23.7 88.7 56.3 65.5 9.9 95.7 
Symptom Validity Index         
Optimal Sensitivity  1.5 49.5 89.7 24.2 42.7 79.0 5.9 97.8 
Optimal Specificity  15.5 66.3 28.2 90.3 64.7 66.7 13.3 96.0 	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Table 22 
 
Optimal Sensitivity and Specificity Thresholds and Associated Psychometric Properties for the MARS Indexes Predicting Malingering 
between ADHD and Malingering groups 
    
58.9% Base Rate (Current Study) 
 
30% Base Rate 
 
Index Cut Score 
Correct 
Classification 
 
Sensitivity 
 
Specificity 
 
PPP 
 
NPP 
 
PPP 
 
NPP 
ADHD Inattentive Index         
Optimal Sensitivity  43.5 74.7 91.1 51.3 72.9 80.0 44.5 93.1 
Optimal Specificity  55.5 74.7 62.5 92.3 92.1 63.2 77.7 85.2 
ADHD Hyperactivity-
Impulsivity Index  
       
Optimal Sensitivity  42.5 84.2 89.3 76.9 84.8 83.3 62.4 94.4 
Optimal Specificity  49.5 81.1 75.0 89.7 91.3 71.4 75.7 89.3 
ADHD Total Index         
Optimal Sensitivity  94.5 86.3 87.5 84.6 89.1 82.5 70.9 94.0 
Optimal Specificity  100.5 83.2 78.6 89.7 91.7 74.5 76.6 90.7 
Functional Impairment 
Index  
       
Optimal Sensitivity  72.0 77.7 89.3 60.5 76.9 79.3 49.2 93.0 
Optimal Specificity  127.5 70.2 57.1 89.5 88.9 58.6 70.0 83.0 
Symptom Validity Index         
Optimal Sensitivity  24.5 88.4 89.3 87.2 90.9 85.0 74.9 95.0 
Optimal Specificity  28.0 83.2 78.6 89.7 91.7 74.5 76.6 90.7 	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Appendix A 
Study Invitation Letter  
 
SYRACUSE UNIVERSITY 
DEPARTMENT OF PSYCHOLOGY 
430 HUNTINGTON HALL 
SYRACUSE, NY 13244 
 
Invitation Letter to Participate in Research Study 
My name is Heather Potts and I am a Graduate Student at Syracuse University.  I am conducting research 
as part of my graduate studies and I am inviting you to participate in this study. 
I am interested in learning more about accurately diagnosing ADHD in college students. For this part of 
the study, we are recruiting individuals a) between the ages of 18-26 and b) those who have a diagnosis of 
ADHD.  If you decide to participate, you will be emailed the link to complete the online materials.  First, 
you will be asked to complete a brief demographic questionnaire so we can collect some background 
information about you.  The next form is a list of questions on a self-report measure for ADHD.  We ask 
that you complete each item honestly as they pertain to you.  The final measure will be a brief exit survey 
about your experience and effort during the study.  The entire study will take approximately 45 minutes of 
your time.   
All information will be kept confidential.  This means that your name will not appear anywhere and your 
specific answers will not be linked to your name in any way.  Your ScreeningID/name will only be 
connected to reimbursement.  In addition, all of your information will be used for research purposes only.  
We also believe that this study should involve minimal risk to you. 
Taking part in this research study is optional and your decision and you have the right to both participate, 
and the option to opt-out at any time. 
In compensation for your time, participants who complete the study will receive $20 cash and be entered 
into a raffle drawing for a $100 Visa gift card. The researchers will notify the winner of the raffle directly 
after the completion of the study.   
I am happy to answer any questions that you may have.  Please contact me, Heather Potts at 
hepotts@syr.edu if you have questions, concerns, or are interested in participating. 
Thank you for your time and consideration.   
Sincerely, 
Heather Potts 
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Appendix B 
Study Flyer 
ONLINE RESEARCH STUDY FOR 
 
ADULTS WITH ADHD 
BETWEEN THE AGES OF 18-26 	  What	  is	  the	  study?	  
• Online	  Pilot	  ADHD	  Self-­‐Report	  Measure	  
• Takes	  less	  than	  45	  minutes	  
• All	  information	  is	  kept	  confidential	  	  Where	  can	  I	  complete	  the	  study?	  
• Anywhere	  with	  Internet	  access	  	  What	  is	  the	  compensation?	  
• $20	  cash	  
• Entered	  into	  a	  $100	  Visa	  Gift	  Card	  Raffle	  drawing	  	   For	  more	  information	  and	  	  to	  complete	  the	  eligibility	  screening	  please	  contact:	  Heather	  Potts	  hepotts@syr.edu	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Appendix C 
Multidimensional ADHD Rating Scale 
Multidimensional ADHD Rating Scale 
Instructions: This self-report measure contains TWO Sections.  Please read each Section Header 
carefully with directions on the rating scale for those items. 
Section 1: 
Please indicate by circling the number associated with the response that  
best describes your behavior OVER THE PAST 6 MONTHS, from  
Never, Rarely, Sometimes, Often, to Very Often 
 
	  
 
DSM-5 ADHD Symptom Items 
 
1. Fail to give close attention 
to details or make careless 
mistakes in my work 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	  	  
2. Lose things necessary for 
tasks or activities 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	  	  
3. Forgetful in daily activities 0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
4. Difficulty organizing tasks 
and activities 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
5. Easily distracted by 
extraneous stimuli or 
irrelevant thoughts 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
6. Difficulty sustaining 
attention in tasks or play 
activities 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
7. Do not listen when spoken 
to directly (mind seems 
elsewhere) 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
8. Avoid, dislike, or reluctant 
to engage in tasks that 
require sustained mental 
effort 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
9. Do not follow through with 
instructions and fail to 
finish schoolwork, chores, 
or work duties 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
10. Leave my seat when 
remaining seated is 
expected 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
11. Blurt out an answer before 0          1          2          3          4          5           6           7           8    
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a question has been 
completed 
Never           Rarely                Sometimes             Often          Very Often	   
12. Fidget in seat by 
squirming, tapping my 
hands and/or my feet 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
13. Constantly “on the go” or 
act as if “driven by a 
motor” 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
14.  Unable to play or engage 
in leisure activities quietly  
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
15. Run about or climb in 
situations where it is 
inappropriate 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	  	  
16. Talk excessively  0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
17. Have difficulty waiting for 
my turn 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
18. Interrupt or intrude on 
others (butt into 
conversations or activities 
without permission) 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometimes             Often          Very Often	   
 
SCT Items not included in Present Study 
 
19. Prone to daydreaming 
when I should be 
concentrating on 
something or working  
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
20. Have trouble staying alert 
or awake in boring 
situations 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
21. Easily confused 0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
22. Easily bored 0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
23. Feel spacey or “in a fog” 0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
24. Lethargic, more tired than 
others 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
25. Underactive or have less 
energy than others 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
26. Slow moving 0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
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27. Do not seem to process 
information as quickly or 
as accurately as others 
0          1          2          3          4          5           6           7           8    
Never           Rarely                Sometime                Often          Very Often 
 
104 pilot SV-Items were removed from this document to maintain test security	  	  	  	  
Section 2: 
Please indicate by circling the number associated with the response that fits you the most  
Not At All, Somewhat, Mild, Moderate, or Severe 
If the situation does not apply to you, choose N/A 
In the Past SIX MONTHS I have Experienced Difficulty in Functioning in the Following 
Areas: 
28. In home life with 
immediate family 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
29. In getting household 
chores completed  
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
30. In managing daily 
activities 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
31. In my social interactions 
with strangers 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
32. In my work/job 0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
33. In budgeting my money, 
bills, and/or debt 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
34. In operating a motor 
vehicle 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
35. In my relationships with 
friends 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
36. In my marital, or partner, 
or dating relationships 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
37. In my educational classes 
(e.g., attendance) 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
38. In my performance on 
educational 
tests/assignments 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
39. In controlling my behavior 
at work, home, or school 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
40. In my decision making at 
work, home, or school 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
41. In maintaining hygiene 
(dressing, showing) 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	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42. In self-care (e.g., sleeping, 
eating) 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
43. In social activities 0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
44. In community-based 
activities (e.g., church, 
clubs, organizations) 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe	  
45. In maintaining my health 
(e.g., nutrition, exercise) 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe 
46. In time management 0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe 
47.  In meeting deadlines 0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe 
48. With controlling my anger 0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe 
49. With my memory for daily 
activities 
0          1          2          3          4          5           6           7           8    
Not at All      Somewhat             Mild              Moderate           Severe 
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Appendix D 
 
Phone Screening 
 
ADHD Screening Form 
The Construction of a Comprehensive ADHD Rating Scale:  
A Pilot Study 
Date of Screening _______________ 
Completed by ____________________ 
  Provide Overview of Study Prior to Screening (script below) 
“Thank you for your interest in participating in this study.  We are interested in learning more 
about accurately diagnosing ADHD in college students.	  	  
For this part of the study, we are recruiting individuals between the ages of 18-26 and those who 
have a diagnosis of ADHD.  In order to verify your eligibility to participate, we have some brief 
screening questions to ask you.   But first, let me tell you about the study.  If you are eligible and 
decide to participate, you will be emailed the link to complete the online materials.  First, you 
will be asked to complete a brief demographic questionnaire so we can collect some background 
information about you.  The next form is a list of questions on a self-report measure for ADHD.  
We ask that you complete each item honestly as they pertain to you.  The final measure will be a 
brief exit survey about your experience and effort during the study.  The entire study will take 
approximately 45 minutes of your time 
All information will be kept confidential.  This means that your name will not appear anywhere 
and your specific answers will not be linked to your name in any way.  Your SUID/name will 
only be connected to reimbursement.  In addition, all of your information will be used for 
research purposes only.  We also believe that this study should involve minimal risk to you. 
Taking part in this research study is optional and your decision and you have the right to both 
participate, and the option to opt-out at any time. 
In compensation for your time, participants who return the completed packet will receive $20 
Cash and be entered into a raffle drawing for a $100 Visa gift card. The researchers will notify 
the winner of the raffle directly after the completion of the study.   
That is a summary of the study.  Would you like to continue with the phone screening to 
determine if you are eligible? Yes    No 
If NO 
“Thank you for your time.” Politely discontinue screening. 
NEXT PAGE IF YES 
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If YES 
“Thank you for your continued interest” 
Assign a Screening ID# and Proceed with Questions below 
 
ScreeningID#_____________________ 
 1.	  How	  did	  you	  hear	  about	  the	  study?	  (write	  in)	  
	  
	  
	  
	  
__________________	  2.	  	  Are	  you	  between	  the	  ages	  of	  18-­‐26?	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Yes	  	  	   No	   	  3.	  	  Do	  you	  have	  a	  diagnosis	  of	  ADHD?	  	  	  	  	  	   Yes	  	  	   No	  	  4.	  Were	  you	  diagnosed	  by	  a	  professional?	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Yes	  	  	   No	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  If	  yes,	  what	  type	  of	  professional?	  	  (write	  in)	  	  	  	  	   	  __________________	  	  5.	  	  At	  what	  age	  were	  you	  diagnosed?	  (write	  in)	  	  	  	  	   	  __________________	  6.	  	  Did	  you	  experience	  ADHD	  symptoms	  prior	  to	  the	  age	  of	  12?	   Yes	   	  No	  	  7.	  	  Do	  you	  still	  experience	  symptoms	  of	  ADHD?	  	  	   Yes	  	   No	  	  
	  
	  
	  
Impairment	  8.	  	  In	  the	  past	  6	  months,	  have	  your	  symptoms	  impacted	  you	  in	  your	  everyday	  life?	  	  In	  other	  words,	  have	  your	  symptoms	  caused	  you	  any	  impairment	  or	  difficulty?	  	  	  
• DSM-­‐V	  Definition	  of	  Impairment-­‐	  “Evidence	  that	  
symptoms	  interfere	  with,	  or	  reduce	  the	  quality	  of	  
social,	  academic,	  or	  occupational	  functioning”	  
• Document	  evidence	  of	  impairment	  for	  each	  area	  
• Check	  box	  if	  there	  is	  evidence	  of	  impairment	  
• Provide	  additional	  clarification	  and	  examples	  if	  
needed	  
	  
*Continued	  on	  next	  page	  
Yes	  	   No	  
Check	  if	  individual	  demonstrates	  
impairment	  in	  at	  least	  	  
ONE	  area	  	  	  	  	  	  
	  	   100 
Social	  Functioning	   Yes,	  Evidence	  of	  Impairment	  Academic	  Functioning	   	  Yes,	  Evidence	  of	  Impairment	  Occupational	  Functioning	   	  Yes,	  Evidence	  of	  Impairment	  Additional	  Notes:	  	  
Not Eligible 
“Thank you for your interest and participating in this phone screening.  At this time, you do not 
meet our eligibility criteria for our study.  Again, I appreciate your interest and should you have 
any questions, please do not hesitate to let me know.” 
 
 Eligible if: 
• “Yes” is checked for #2, #3, #6, and #8 
• Diagnosis was made by a qualified mental health provider, psychologist, counselor 
NEXT STEPS if Eligible is checked: 
“You meet the eligibility criteria to participate in our study.  If you are still interested in 
participating, I will email you the hyperlink.  Can you please provide me with the email address 
that you would like me to send the hyperlink to?” 
Email Address to send Hyperlink:___________________________________ 
“In addition, can you please provide us with a home address that we can mail the $10 Visa Gift 
Card once you have completed the study materials?” 
Address to send $20 Compensation: 
                 
“Next, let me provide you with your Screening ID number.  The Screening ID number is the 
unique identifier that verifies you meet the study criteria through this phone screening.  In 
addition, this will alert us once you have completed the online study materials, so we can mail 
you the $10 cash to the address that you have provided us.  You will report this on the 
demographic form."  
Provide Screening ID number (page 2 of form)  
“Do you have any questions?” 
Answer any additional questions about study 
“Thank you again for your interest, and I will email the hyperlink to you soon!” 
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Appendix E 
 
Demographic Questionnaire 
 Age: ________________  
 Sex:   _______________ 
 SU ID:___________________________ 
 Current GPA:  ____________ 
  
 Year in School (Please check) 
 ____Freshman 
 ____Sophomore 
____Junior 
____Senior 
____Other 
____Graduate 
  
 Ethnicity: (Please check) 
____American Indian or Alaska Native 
____ Asian  
____ Black or African American  
____ Hispanic or Latino  
____ Native Hawaiian or Other Pacific Islander 
____ White 
 
Primary language:  
(Please Circle)  English  Other:_______________________ 
 
 Please check any disorder with which you have been diagnosed 
____ADHD/ADD   _____Anxiety Disorder         
____Learning Disability   _____ Traumatic Brain Injury 
____Vision Impairment  _____ Autism  
____Hearing Impairment  _____ Other:_______  
____Depression   _____ None 
 
Are you currently experiencing any difficulties related to school? 
 No  Yes 
 If Yes, please explain:_________________________________ 
  
Are you currently taking any medications?  
No  Yes 
If so, what is (are) the medication(s) treating? ____________________ 
  
Do you regularly take stimulant medication (e.g., Ritalin, Adderall)?  
No  Yes
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Appendix F 
 
Exit Survey-ADHD and Control Groups 
 
I believe that I put forth my best effort on the self-report measure 
(Please Circle)  No  Yes 
 If No, Please Explain:________________________________________________ 
 
I completed the research materials (e.g. self-report measure) honestly and accurately 
(Please Circle)  No  Yes 
 If No, Please Explain:________________________________________________ 
 
Prior to this study, were you aware of the symptoms of ADHD  
(Please Circle)  No  Yes 
 
Prior to this study, I would rank my knowledge of ADHD on a scale of 0-8 as: 
0           1           2           3           4           5           6           7           8    
              No                           Little                     Good                   Very Good       Superior 
          Knowledge                                          Knowledge 
 
Prior to this study, I learned about ADHD from: 
(Check all that apply) 
____Friend has ADHD     ____TV Advertisements 
____Family member has ADHD   ____Brochures/Pamphlets 
____Online websites    ____News reports 
____Research into ADHD (Journal Articles) 
____I do not have any knowledge about ADHD 
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Appendix G 
 
Exit Survey-Malingering Group 
 
I believe that I put forth my best effort on the self-report measure 
(Please Circle)  No  Yes 
 If No, Please Explain:_______________________________________________ 
 
I completed the research materials (e.g. self-report measure) honestly and accurately 
(Please Circle)  No  Yes 
 If No, Please Explain:________________________________________________ 
 
Prior to this study, were you aware of the symptoms of ADHD  
(Please Circle)  No  Yes 
 
Prior to this study, I would rank my knowledge of ADHD on a scale of 0-8 as: 
0           1           2           3           4           5           6           7           8    
              No                           Little                     Good                   Very Good      Superior 
          Knowledge                                          Knowledge 
 
Prior to this study, I learned about ADHD from: 
(Check all that apply) 
____Friend has ADHD     ____TV Advertisements 
____Family member has ADHD  ____Brochures/Pamphlets 
____Online websites    ____News reports 
____Research into ADHD (Journal Articles) 
____I do not have any knowledge about ADHD 
 
I feel like the ADHD scenario at the beginning of the study was necessary for me to read in order 
to successfully fake the symptoms of ADHD 
(Please Circle)  No  Yes 
 
I believe that I was successful in faking ADHD 
(Please Circle)  No  Yes 
 
I used the following strategies while taking this ADHD self-report measure  
(Check all that apply) 
____Selected items that best matched the DSM-V Criteria (provided in handout) 
____ Selected items that best matched my previous knowledge of ADHD 
____ Selected items that best matched a person I know with ADHD 
____ Impulsive with response selection 
____ Did not read instructions fully  
____ Completed tasks slowly 
____ Skipped items 
____Re-read items 
____ Selected items about Inattention 
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____ Selected items about Hyperactivity 
____ Letting mind wander or “zoning out” 
____ Other:_________________________________ 
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Appendix H 
Debriefing Letter  
 
SYRACUSE UNIVERSITY 
DEPARTMENT OF PSYCHOLOGY 
430 HUNTINGTON HALL 
SYRACUSE, NY 13244 
 
Developing a Self-Report Measure to Assess ADHD 
Thank you again for participating in this study.  
 
The purpose of this study is to learn more about accurately diagnosing ADHD in college 
students.  We asked for you to complete a self-report measure as if you had ADHD.  We 
specifically informed you that only those who are successful would be entered into a raffle 
drawing. This is because studies have found that performance increases when individuals are told 
that they will be given an incentive for demonstrating effort.    
 
This is to notify you that all participants in this study who completed the materials (regardless of 
performance) are being entered into the raffle drawing for $100 Visa gift card.  
Thank you again for your time and participation.  If you have any questions, concerns, 
complaints about the research, please contact the Heather Potts at hepotts@syr.edu, Lawrence 
Lewandowski at 315-443-1015 or ljlewand@syr.edu.  If you have any questions about your 
rights as a research participant, you have questions, concerns, or complaints that you wish to 
address to someone other than the investigator, if you cannot reach the investigator contact the 
Syracuse University Institutional Review Board at 315-443-3013.  
Thank you, 
Heather Potts 
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Appendix I 
Informed Consent: ADHD group 
 
SYRACUSE UNIVERSITY 
DEPARTMENT OF PSYCHOLOGY 
430 HUNTINGTON HALL 
SYRACUSE, NY 13244 
 
Developing a Self-Report Measure to Assess ADHD 
 
My name is Heather Potts and I am a Graduate Student at Syracuse University.  I am inviting 
you to participate in a research study. Involvement in the study is voluntary, so you may choose 
to participate or not. This sheet will explain the study to you and please feel free to ask questions 
about the research if you have any. I will be happy to explain anything in detail if you wish.  
I am interested in learning more about accurately diagnosing ADHD in college students.  You 
will begin by completing a brief demographic questionnaire.  Next, you will be asked to 
complete a list of questions on a self-report measure for ADHD.  We ask that you complete each 
item honestly as they pertain to you.  The final measure will be a brief exit survey about your 
experience and effort during the study.  The entire study will take approximately 45 minutes of 
your time.  All information will be kept confidential.  This means that your name will not appear 
anywhere and your specific answers will not be linked to your name in any way.    
To compensate for your time and effort, you will receive $20 cash for participating in this study.  
As an additional incentive for participating, you also will be entered into a raffle drawing for a 
$100 Visa gift card.  The odds of winning the raffle are approximately 1 in 150.  The researchers 
will notify the winner of the raffle directly after the completion of the study.   
Through participation, you will be contributing to the development of a self-report measure to 
diagnosis ADHD.  A benefit to you might be an increased understanding about ADHD.  We 
believe that this study should involve minimal risk to you.  Although not seen in previous 
studies, you may become concerned about your answers on the self-report measure.  If you do 
not want to take part, you have the right to refuse to take part, without penalty. If you decide to 
take part and later no longer wish to continue, you have the right to withdraw from the study at 
any time, without penalty.  Please inform the researcher if you have any questions, concerns, or 
would like to be provided with local counseling and psychological services information. 
Whenever one works with e-mail or the Internet there is always the risk of compromising 
privacy, confidentiality and/or anonymity. Your confidentiality will be maintained to the degree 
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permitted by the technology being used. It is important for you to understand that no guarantees 
can be made regarding the interception of data sent via the Internet by third parties. 
If you have any questions, concerns, complaints about the research, please contact the Heather 
Potts at hepotts@syr.edu or Lawrence Lewandowski at 315-443-1015 or ljlewand@syr.edu.  If 
you have any questions about your rights as a research participant, you have questions, concerns, 
or complaints that you wish to address to someone other than the investigator, if you cannot 
reach the investigator contact the Syracuse University Institutional Review Board at 315-443-
3013.  
All of my questions have been answered, I am 18 years of age or older, and I wish to participate 
in this research study.  
Please print a copy of this informed consent for your records. 
By clicking here I agree to participate in this research study.  
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Appendix J 
 
Informed Consent: Control Group 
 
SYRACUSE UNIVERSITY 
DEPARTMENT OF PSYCHOLOGY 
430 HUNTINGTON HALL 
SYRACUSE, NY 13244 
 
Developing	  a	  Self-­‐Report	  Measure	  to	  Assess	  ADHD	  
 
My name is Heather Potts and I am a Graduate Student at Syracuse University.  I am inviting 
you to participate in a research study. Involvement in the study is voluntary, so you may choose 
to participate or not. This sheet will explain the study to you and please feel free to ask questions 
about the research if you have any. I will be happy to explain anything in detail if you wish.  
I am interested in learning more about accurately diagnosing ADHD in college students.  You 
will begin by completing a brief demographic questionnaire.  Next, you will be asked to 
complete a list of questions on a self-report measure for ADHD.  We ask that you complete each 
item honestly as they pertain to you.  The final measure will be a brief exit survey about your 
experience and effort during the study.  The entire study will take approximately 45 minutes of 
your time.  All information will be kept confidential.  This means that your name will not appear 
anywhere and your specific answers will not be linked to your name in any way.    
You will earn 1 research credit hour through Sona for participating in this study.  If you decide to 
withdrawal from the study, you will receive .5 research credit hour for time that you did 
participate (5-30 minutes). As an additional incentive, those that complete all items of the self-
report measure will be entered into a raffle drawing for a Visa gift card of $100. The odds of 
winning the raffle are approximately 1 in 150.  The researchers will notify the winner of the 
raffle directly after the completion of the study.   
Through participation, you will be contributing to the development of a self-report measure to 
diagnosis ADHD.  A benefit to you might be an increased understanding about ADHD.  We 
believe that this study should involve minimal risk to you.  Although not seen in previous 
studies, you may become concerned about your answers on the self-report measure.  If you do 
not want to take part, you have the right to refuse to take part, without penalty. If you decide to 
take part and later no longer wish to continue, you have the right to withdraw from the study at 
any time, without penalty.  Please inform the researcher if you have any questions, concerns, or 
would like to be provided with local counseling and psychological services information. 
Whenever one works with e-mail or the Internet there is always the risk of compromising 
privacy, confidentiality and/or anonymity. Your confidentiality will be maintained to the degree 
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permitted by the technology being used. It is important for you to understand that no guarantees 
can be made regarding the interception of data sent via the Internet by third parties. 
If you have any questions, concerns, complaints about the research, please contact the Heather 
Potts at hepotts@syr.edu or Lawrence Lewandowski at 315-443-1015 or ljlewand@syr.edu.  If 
you have any questions about your rights as a research participant, you have questions, concerns, 
or complaints that you wish to address to someone other than the investigator, if you cannot 
reach the investigator contact the Syracuse University Institutional Review Board at 315-443-
3013.  
All of my questions have been answered, I am 18 years of age or older, and I wish to participate 
in this research study.  
Please print a copy of this informed consent for your records. 
By clicking here I agree to participate in this research study.  
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Appendix K  
 
Informed Consent: Malingering Group 
 
SYRACUSE UNIVERSITY 
DEPARTMENT OF PSYCHOLOGY 
430 HUNTINGTON HALL 
SYRACUSE, NY 13244 
 
Developing a Self-Report Measure to Assess ADHD 
 
My name is Heather Potts and I am a Graduate Student at Syracuse University.  I am inviting 
you to participate in a research study. Involvement in the study is voluntary, so you may choose 
to participate or not. This sheet will explain the study to you and please feel free to ask questions 
about the research if you have any. I will be happy to explain anything in detail if you wish.  
I am interested in learning more about accurately diagnosing ADHD in college students.  You 
will begin by completing a brief demographic questionnaire.  Next, you will be asked to 
complete a list of questions on a self-report measure for ADHD.  We ask that you complete each 
item honestly as they pertain to you.  The final measure will be a brief exit survey about your 
experience and effort during the study.  The entire study will take approximately 45 minutes of 
your time.  All information will be kept confidential.  This means that your name will not appear 
anywhere and your specific answers will not be linked to your name in any way.    
You will earn 1 research credit hour through Sona for participating in this study.  If you decide to 
withdrawal from the study, you will receive .5 research credit hour for time that you did 
participate (5-30 minutes). As an additional incentive, those that successfully convince the 
researcher that they have ADHD will be entered into a raffle drawing for a Visa gift card of 
$100.  The odds of winning the raffle are approximately 1 in 150.  The researchers will notify the 
winner of the raffle directly after the completion of the study.   
Through participation, you will be contributing to the development of a self-report measure to 
diagnosis ADHD.  A benefit to you might be an increased understanding about ADHD.  We 
believe that this study should involve minimal risk to you.  Although not seen in previous 
studies, you may become concerned about your answers on the self-report measure.  If you do 
not want to take part, you have the right to refuse to take part, without penalty. If you decide to 
take part and later no longer wish to continue, you have the right to withdraw from the study at 
any time, without penalty.  Please inform the researcher if you have any questions, concerns, or 
would like to be provided with local counseling and psychological services information. 
Whenever one works with e-mail or the Internet there is always the risk of compromising 
privacy, confidentiality and/or anonymity. Your confidentiality will be maintained to the degree 
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permitted by the technology being used. It is important for you to understand that no guarantees 
can be made regarding the interception of data sent via the Internet by third parties. 
If you have any questions, concerns, complaints about the research, please contact the Heather 
Potts at hepotts@syr.edu or Lawrence Lewandowski at 315-443-1015 or ljlewand@syr.edu.  If 
you have any questions about your rights as a research participant, you have questions, concerns, 
or complaints that you wish to address to someone other than the investigator, if you cannot 
reach the investigator contact the Syracuse University Institutional Review Board at 315-443-
3013.  
All of my questions have been answered, I am 18 years of age or older, and I wish to participate 
in this research study.  
Please print a copy of this informed consent for your records. 
By clicking here I agree to participate in this research study.  
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Appendix L 
Malingering Group Study Materials 
The	  Scenario	  
You will be given 5 minutes to read the following information.  At the end of 5 minutes, you will 
return the information and take a self-report measure as if you are trying to convince someone 
that you have ADHD.  It is not necessary for you to try to act like you have ADHD; you only 
need to respond to the test items as if you do. Remember, if you are successful at deceiving the 
tests and following instructions throughout, you will be entered into a raffle drawing to win $100 
Visa gift card!  
 
Your roommate has been diagnosed with ADHD.  He/She had trouble with classes, but then was 
given some medication for ADHD, and now does well. He/She even got a couple of A’s 
recently, and has more time to socialize because studying is not as hard! During your midterms, 
you decided to try your roommate’s medication, and ended up surprising yourself with how 
much easier things went. You may think that you have undiagnosed ADHD, so you “Google” the 
disorder to learn more about it. On the following pages are some of the things that you find. 
 
 
Attention	  Deficit	  Hyperactivity	  Disorder	  
The symptoms of ADHD include inattention and/or hyperactivity and impulsivity. These are 
traits that most children display at some point or another. But to establish a diagnosis of ADHD, 
sometimes referred to as ADD, the symptoms should be inappropriate for the child's age. 
Adults also can have ADHD; in fact, up to half of adults diagnosed with the disorder had it as 
children.  When ADHD persists into adulthood, symptoms may vary. For instance, an adult may 
experience restlessness instead of hyperactivity. In addition, adults with ADHD often have 
problems with interpersonal relationships and employment. 
 
Symptoms of ADHD 
There are three different categories of ADHD symptoms: inattention, hyperactivity, impulsivity. 
Inattention may not become apparent until a child enters the challenging environment of school. 
In adults, symptoms of inattention may manifest in work or in social situations. 
A person with ADHD may have some or all of the following symptoms: 
• Difficulty paying attention to details and tendency to make careless mistakes in school or 
other activities; producing work that is often messy and careless 
• Easily distracted by irrelevant stimuli and frequently interrupting ongoing tasks to attend 
to trivial noises or events that are usually ignored by others 
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• Inability to sustain attention on tasks or activities 
• Difficulty finishing schoolwork or paperwork or performing tasks that require 
concentration 
• Frequent shifts from one uncompleted activity to another 
• Procrastination 
• Disorganized work habits 
• Forgetfulness in daily activities (for example, missing appointments, forgetting to bring 
lunch) 
• Failure to complete tasks such as homework or chores 
• Frequent shifts in conversation, not listening to others, not keeping one's mind on 
conversations, and not following details or rules of activities in social situations 
Hyperactivity symptoms may be apparent in very young preschoolers and are nearly always 
present before the age of seven. Symptoms include: 
• Fidgeting, squirming when seated 
• Getting up frequently to walk or run around 
• Running or climbing excessively when it's inappropriate (in teens this may appear as 
restlessness) 
• Having difficulty playing quietly or engaging in quiet leisure activities 
• Always being 'on the go' 
• Often talking excessively 
Hyperactivity may vary with age and developmental stage. 
Toddlers and preschoolers with ADHD tend to be constantly in motion, jumping on furniture, 
and having difficulty participating in sedentary group activities. For instance, they may have 
trouble listening to a story. 
School-age children display similar behavior but with less frequency. They are unable to remain 
seated, squirm a lot, fidget, or talk excessively. 
In adolescents and adults, hyperactivity may manifest itself as feelings of restlessness and 
difficulty engaging in quiet sedentary activities. 
Impulsivity symptoms include: 
• Impatience 
• Difficulty delaying responses 
• Blurting out answers before questions have been completed 
• Difficulty awaiting one's turn 
• Frequently interrupting or intruding on others to the point of causing problems in social 
or work settings 
• Initiating conversations at inappropriate times 
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Impulsivity may lead to accidents such as knocking over objects or banging into people. 
Children with ADHD may also engage in potentially dangerous activities without considering 
the consequences. For instance, they may climb to precarious positions. 
Many of these symptoms occur from time to time in normal youngsters. However, in children 
with ADHD they occur frequently -- at home and at school or when visiting with friends. They 
also interfere with the child's ability to function as other children of the same age or 
developmental level.  
ADHD is diagnosed only when children consistently display some or all of the above behaviors 
in at least two settings, such as at home and in school, for at least six months. 
Types of ADHD 
There are three different subtypes of ADHD, including: 
• Combined ADHD (the most common subtype), which involves symptoms of both 
inattentiveness and hyperactivity/impulsivity 
• Inattentive ADHD (previously known as ADD), which is marked by impaired attention 
and concentration 
• Hyperactive-impulsive ADHD, which is marked by hyperactivity without inattentiveness 
For a diagnosis of ADHD, some symptoms that cause impairment must be present before age 
seven. Also, some impairment from the symptoms must be present in more than one setting. For 
instance, the person may be impaired at home and school or home and work. Also, there must be 
clear evidence the symptoms interfere with the person's ability to function at home, in social 
environments, or at work. 
How is ADHD diagnosed in adults? 
Like children, adults who suspect they have ADHD should be evaluated by a licensed mental 
health professional. But the professional may need to consider a wider range of symptoms when 
assessing adults for ADHD because their symptoms tend to be more varied and possibly not as 
clear-cut as symptoms seen in children. 
To be diagnosed with the condition, an adult must have ADHD symptoms that began in 
childhood and continued throughout adulthood. Health professionals use certain rating scales to 
determine if an adult meets the diagnostic criteria for ADHD. The mental health professional 
also will look at the person's history of childhood behavior and school experiences, and will 
interview spouses or partners, parents, close friends, and other associates. The person will also 
undergo a physical exam and various psychological tests. 
For some adults, a diagnosis of ADHD can bring a sense of relief. Adults who have had the 
disorder since childhood, but who have not been diagnosed, may have developed negative 
feelings about themselves over the years. Receiving a diagnosis allows them to understand the 
reasons for their problems, and treatment will allow them to deal with their problems more 
effectively. 
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Who	  Is	  At	  Risk?	  
ADHD is one of the most common childhood disorders and can continue through adolescence 
and into adulthood. The average age of onset is 7 years old. 
ADHD affects about 4.1% American adults age 18 years and older in a given year. The disorder 
affects 9.0% of American children age 13 to 18 years. Boys are four times at risk than girls. 
Studies show that the number of children being diagnosed with ADHD is increasing, but it is 
unclear why. 
Long-Term Prognosis With ADHD 
Some children with ADHD -- approximately 20% to 30% -- develop learning problems that may 
not improve with ADHD treatment. Hyperactive behavior may be associated with the 
development of other disruptive disorders, particularly conduct and oppositional-defiant 
disorder. Why this association exists is not known. 
Many children with ADHD ultimately adjust. Some, though, especially those with an associated 
conduct or oppositional-defiant disorder, are more likely to drop out of school. These individuals 
fare more poorly in their later careers. 
Inattention tends to persist through childhood and adolescence and on into adulthood, while 
hyperactivity tends to diminish with age. 
As they grow older, some teens that have had ADHD since childhood may experience periods of 
anxiety or depression. 
Several of the symptoms of ADHD may get worse as the demands at school or home increase. 
They include: 
• Difficulty following instructions 
• Being unable to get organized, either at home or at school 
• Fidgeting, especially with the hands and feet 
• Talking too much 
• Failing to finish projects, including chores and homework 
• Not paying attention to and responding to details 
• Getting poor grades in school 
• Being isolated from peers due to poor grades and secondary depressio 
 
 
Please Continue to Study these Materials Until Instructed to Stop by the Researcher 
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Appendix M 
Procedural Script: Control Condition 
Developing	  a	  Self-­‐Report	  Measure	  to	  Assess	  ADHD	  
Procedural	  SCRIPT	  
CONTROL	  CONDITION	  Directions:	  	  Please	  fill	  out	  each	  area	  detailed	  below.	  Please	  make	  sure	  that	  the	  identifying	  information	  (box	  1)	  is	  complete	  before	  you	  submit	  the	  form.	  
I.	  	  	   Identifying	  Information	  
Name	  of	  primary	  research	  assistant:	  
Name	  of	  secondary	  research	  assistant:	  	  	   	   	   	   	  	  	  	  	  	  	  	  	  or	  N/A	  
Date	  and	  Time:	  
Number	  of	  Participants:	  
Session	  Number:	   	  
Session	  	  Preparation	  
Set	  up	  Computers	  
• Username:	  m-­‐kdpotter	  
• Password:	  Testing1	  
Load	  Qualtrics	  
• Desktop	  Word	  document	  “ADHD	  Link”	  
• Open	  the	  Control	  
• Put	  sign	  in	  sheet	  by	  door	  
	  
Study	  Protocol	  	  
• Sign	  in	  sheet	  
• Informed	  Consent	  
• Demographic	  survey	  introduction	  
• Self-­‐Report	  and	  Exit	  Survey	  introduction	  	  
Check	  out	  
• Log	  Off	  	  
II.	   Data	  Collection	  –	  Material	  Preparation	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Circle	  
1.	   Informed	  Consents	   Yes	   No	  
2.	   Note	  Pad	  and	  Pen	   Yes	   No	  
Notes:	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  Informed	  Consent	  and	  Welcome	  Procedures	  	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   State	  to	  the	  students:	  	  	  
Welcome!	  	  We	  are	  going	  to	  get	  started.	  If	  you	  have	  not	  already	  done	  so,	  
please	  clean	  off	  the	  top	  of	  your	  desk,	  except	  for	  the	  packet	  and	  pencils.	  	  
Please	  also	  turn	  off	  all	  electronics.	  
If	  you	  have	  not	  already	  done	  so,	  please	  make	  sure	  to	  put	  your	  name	  on	  
the	  sign	  in	  sheet	  for	  us	  to	  assign	  Sona	  credit	  hours.	  
	  
2	   Review	  Informed	  Consent:	  
This	  study	  will	  be	  conducted	  online.	  	  The	  online	  survey	  has	  been	  loaded	  
for	  you,	  	  
We	  are	  asking	  that	  you	  participate	  in	  a	  study	  to	  develop	  a	  self-­‐report	  
measure	  to	  assess	  for	  ADHD.	  	  We	  will	  be	  asking	  you	  to	  complete	  a	  
demographic	  survey,	  a	  pilot	  self-­‐report	  measure,	  and	  an	  exit	  survey.	  	  For	  
your	  participation	  in	  this	  study,	  you	  will	  receive	  Sona	  credit	  and	  be	  
entered	  into	  a	  $100	  Visa	  gift	  card	  raffle	  drawing.	  
We	  do	  not	  believe	  that	  you	  will	  experience	  any	  risk	  with	  your	  
participation	  today,	  however	  should	  you	  have	  questions	  or	  concerns	  
later	  you	  can	  always	  contact	  us.	  	  Please	  review	  the	  informed	  consent	  and	  
please	  let	  us	  know	  if	  you	  have	  any	  questions.	  	  If	  you	  agree	  to	  participate,	  
please	  electronically	  sign	  the	  document.	  	  Paper	  copies	  are	  available	  for	  
you	  to	  take	  home.	  
	  
3.	   Please	  review	  the	  informed	  consent	  and	  let	  us	  know	  if	  you	  have	  any	  
questions.	  Experimenter	  walks	  around	  and	  answers	  any	  questions	   	  4.	   Thank	  you,	  we	  will	  begin.	  	  Please	  make	  sure	  to	  listen	  to	  the	  directions	  
carefully,	  including	  instructions	  regarding	  when	  to	  move	  on	  to	  the	  next	  
section.	  	  Are	  there	  any	  questions?	  	  	  
	  
5	   Please	  move	  onto	  the	  next	  section	   	  
	   Demographic	  Information	  	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   Experimenter	  introduces	  demographics	  form.	  	  
The	  first	  section	  is	  a	  demographic	  survey.	  We	  are	  asking	  for	  you	  to	  
include	  your	  SUID.	  	  This	  will	  be	  used	  only	  for	  the	  final	  raffle	  drawing	  and	  
to	  assign	  Sona	  credits.	  	  Your	  SUID	  will	  not	  be	  connected	  to	  any	  of	  your	  
responses.	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2	   If	  you	  have	  any	  questions	  about	  these,	  just	  raise	  your	  hand,	  and	  one	  of	  us	  
will	  come	  over	  to	  help	  you.	  
	  
3.	   Walk	  around	  and	  answer	  any	  questions	   	  	   	  Self-­‐Report	  Measure	  and	  Exit	  Survey	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   Experimenter	  introduces	  the	  Self-­‐Report	  Measure	  and	  Exit	  Survey	  	  
In	  the	  next	  task,	  we’ll	  be	  asking	  you	  to	  complete	  a	  Self-­‐report	  measure	  
followed	  by	  a	  brief	  exit	  survey.	  The	  self-­‐report	  measure	  has	  two	  parts.	  	  	  
Please	  make	  sure	  to	  	  take	  time	  to	  read	  each	  section’s	  introduction	  
header,	  as	  this	  will	  tell	  you	  the	  different	  response	  options.	  
	  
2	   For	  all	  survey	  items,	  please	  answer	  honestly	  based	  upon	  how	  you	  think	  
and	  feel,	  NOT	  how	  others	  think	  and	  feel	  and	  NOT	  based	  upon	  how	  others	  
expect	  you	  to	  respond.	  	  Answer	  honestly	  based	  upon	  how	  you	  think	  and	  
feel	  	  	  	  In	  addition,	  please	  let	  me	  know	  if	  you	  have	  any	  questions.	  
You	  must	  provide	  an	  answer	  for	  each	  item	  to	  move	  onto	  the	  next	  section.	  
	  
3	   After	  you	  have	  completed	  the	  Two	  Part	  self-­‐report	  measure	  you	  will	  
complete	  a	  brief	  exit	  survey.	  
	  4	   Please	  check	  in	  when	  you	  have	  completed	  the	  exit	  survey	  and	  please	  let	  
us	  know	  if	  you	  have	  any	  questions.	  
	  5.	   You	  may	  begin	  to	  take	  the	  survey.	  	  Again,	  please	  answer	  these	  items	  
honestly	  as	  they	  related	  to	  you.	  
	  2	   Experimenter	  walks	  around	  answers	  any	  questions	   	  3.	   Thank	  participants	  when	  they	  have	  completed	  the	  exit	  survey	  and	  inform	  them	  that	  they	  are	  free	  to	  leave.	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Appendix N 
 
Procedural Script: Malingering Condition 
 
Developing	  a	  Self-­‐Report	  Measure	  to	  Assess	  ADHD	  
Procedural	  SCRIPT	  
MALINGERING	  CONDITION	  	  Directions:	  	  Please	  fill	  out	  each	  area	  detailed	  below.	  Please	  make	  sure	  that	  the	  identifying	  information	  (box	  1)	  is	  complete	  before	  you	  submit	  the	  form.	  
I.	  	  	   Identifying	  Information	  
Name	  of	  primary	  research	  assistant:	  
Name	  of	  secondary	  research	  assistant:	  	  	   	   	   	   	  	  	  	  	  	  	  	  	  or	  N/A	  
Date	  and	  Time:	  
Number	  of	  Participants:	  
Session	  Number:	   	  
Session	  	  Preparation	  
Set	  up	  Computers	  
• Username:	  m-­‐kdpotter	  
• Password:	  Testing1	  
Load	  Qualtrics	  
• Desktop	  Word	  document	  “ADHD	  Link”	  
• Open	  Malingering	  Condition	  link	  	  
• Put	  sign	  in	  sheet	  by	  the	  door	  
	  
Study	  Protocol	  	  
• Verify	  everyone	  has	  signed	  in	  
• Informed	  Consent	  
• Demographic	  survey	  introduction	  
• Introduction	  to	  Self-­‐Report	  measure	  (Malingering)	  
• Study	  Materials-­‐5	  minute	  study	  time	  
• Self-­‐report	  measure	  	  
• Exit	  Survey	  
• Debriefing	  letter	  	  
II.	   Data	  Collection	  –	  Material	  Preparation	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Circle	  
1.	   Extra	  Informed	  Consents	   Yes	   No	  
2.	   Note	  Pad	  and	  Pen	   Yes	   No	  
Notes:	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  Informed	  Consent	  and	  Welcome	  Procedures	  	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   State	  to	  the	  students:	  	  	  
Welcome!	  	  We	  are	  going	  to	  get	  started.	  If	  you	  have	  not	  already	  done	  so,	  
please	  clean	  off	  the	  top	  of	  your	  desk,	  except	  for	  the	  packet	  and	  pencils.	  	  
Please	  also	  turn	  off	  all	  electronics.	  
If	  you	  have	  not	  already	  done	  so,	  please	  make	  sure	  to	  put	  your	  name	  on	  
the	  sign	  in	  sheet	  for	  us	  to	  assign	  Sona	  credit	  hours.	  
	  
2	   Review	  Informed	  Consent:	  
This	  study	  will	  be	  conducted	  online.	  	  The	  online	  survey	  has	  been	  loaded	  
for	  you,	  	  
We	  are	  asking	  that	  you	  participate	  in	  a	  study	  to	  develop	  a	  self-­‐report	  
measure	  to	  assess	  for	  ADHD.	  	  We	  will	  be	  asking	  you	  to	  complete	  several	  a	  
demographic	  survey,	  a	  pilot	  self-­‐report	  measure,	  and	  an	  exit	  survey.	  	  	  
We	  do	  not	  believe	  that	  you	  will	  experience	  any	  risk	  with	  your	  
participation	  today,	  however	  should	  you	  have	  questions	  or	  concerns	  
later	  you	  can	  always	  contact	  us.	  	  Please	  review	  the	  informed	  consent	  and	  
please	  let	  us	  know	  if	  you	  have	  any	  questions.	  	  If	  you	  agree	  to	  participate,	  
please	  electronically	  sign	  the	  document.	  	  Paper	  copies	  are	  available	  for	  
you	  to	  take	  home.	  
	  
3.	   Please	  review	  the	  informed	  consent	  and	  let	  us	  know	  if	  you	  have	  any	  
questions.	  Experimenter	  walks	  around	  and	  answers	  any	  questions	   	  4.	   Thank	  you,	  we	  will	  begin.	  	  Please	  make	  sure	  to	  listen	  to	  the	  directions	  
carefully,	  including	  instructions	  regarding	  when	  to	  move	  on	  to	  the	  next	  
section.	  	  Are	  there	  any	  questions?	  	  	  
	  
5.	   Please	  move	  onto	  the	  next	  section.	   	  
	   Demographic	  Information	  Procedure	  	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   Experimenter	  introduces	  demographics	  form.	  	  
The	  first	  section	  is	  a	  demographic	  survey.	  We	  are	  asking	  for	  you	  to	  
include	  your	  SUID.	  	  This	  will	  be	  used	  only	  for	  the	  raffle	  drawing,	  which	  
we	  will	  discuss	  later.	  	  Your	  SUID	  will	  not	  be	  connected	  to	  any	  of	  your	  
responses.	  
If	  you	  have	  any	  questions	  about	  these,	  just	  raise	  your	  hand,	  and	  one	  of	  us	  
will	  come	  over	  to	  help	  you.	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Please	  make	  sure	  to	  wait	  prior	  to	  moving	  onto	  the	  next	  section	  2	   Walk	  around	  and	  answer	  any	  questions	   	  3.	   Wait	  for	  all	  participants	  to	  complete	  demographic	   	  4.	   Okay	  now	  we	  are	  going	  to	  move	  onto	  the	  next	  section.	  	  	   	  	   	  Self-­‐Report	  Measure	  and	  Exit	  Survey	  	  [Please	  check	  [ü ]	  each	  box	  as	  you	  complete	  each	  step]ü 	  1.	   Experimenter	  introduces	  the	  Self-­‐Report	  Measure	  and	  Exit	  Survey	  
In	  the	  next	  task,	  we’ll	  be	  asking	  you	  to	  complete	  the	  Self-­‐report	  measure	  
followed	  by	  a	  brief	  exit	  survey.	  	  
	  
	  
2	   	  
We	  are	  asking	  that	  you	  complete	  a	  Two	  Part	  self-­‐report	  measure	  faking	  
the	  symptoms	  and	  diagnosis	  of	  ADHD.	  	  To	  assist	  you	  with	  this,	  we	  have	  
provided	  you	  with	  study	  materials.	  You	  will	  have	  5	  minutes	  to	  review	  
and	  study	  information	  about	  ADHD.	  	  	  
	  
3.	   	  
In	  order	  to	  increase	  motivation	  and	  effort	  to	  fake	  ADHD,	  we	  are	  entering	  
anyone	  who	  successfully	  deceives	  the	  clinician	  by	  faking	  ADHD	  on	  the	  
Two	  Part	  self-­‐report	  measure	  into	  a	  raffle	  drawing	  to	  win	  a	  Visa	  gift	  card	  
of	  $100.	  	  	  
	  
4.	   Are	  there	  any	  questions?	  Wait	  for	  responses	   	  5.	  	   I	  will	  read	  the	  scenario	  with	  you:	  
Your roommate has been diagnosed with ADHD.  He/She had trouble with 
classes, but then was given some medication for ADHD, and now does well. 
He/She even got a couple of A’s recently, and has more time to socialize 
because studying is not as hard! During your 
midterms, you decided to try your roommate’s medication, and ended up 
surprising yourself with how much easier things went. You may think that you 
have undiagnosed ADHD, so you “Google” the disorder to learn more about it. 
On the following pages are some of the things that you find. 
	  
Please	  spend	  the	  next	  5	  minutes	  studying	  the	  materials.	  	  	  
	  
5.	   Time	  5	  minutes	  	  Walk	  around	  and	  answer	  any	  questions.	  	  	   	  5.	  	   After	  5	  minutes	  has	  elapsed:	  
The	  5	  minute	  study	  time	  is	  over.	  	  Please	  hand	  in	  the	  study	  materials.	  	  	  
	  
	  
6.	   Again,	  your	  goal	  is	  to	  successfully	  fake	  the	  symptoms	  of	  ADHD	  to	  deceive	  
the	  clinician.	  	  Those	  that	  are	  successful	  will	  be	  entered	  into	  a	  raffle	  
drawing	  for	  a	  $100	  Visa	  gift	  Card.	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After	  you	  complete	  the	  Two	  Part	  Self-­‐report	  measure,	  we	  ask	  that	  you	  to	  
fill	  out	  the	  final	  exit	  survey	  HONESTLY.	  7.	   Are	  there	  any	  questions?	   	  8.	   You	  may	  begin.	  	  Please	  notify	  me	  when	  you	  are	  done.	   	  9.	   Walk	  around	  and	  answer	  any	  questions.	   	  10.	   Hand	  the	  debriefing	  letter	  to	  participants	  when	  they	  are	  done.	  	  	   	  11.	  	   Thank	  participants	  as	  they	  leave.	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